<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-09133R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Molecular Biology/Bioinformatics</subject><subject>Molecular Biology/Chromatin Structure</subject><subject>Molecular Biology/DNA Repair</subject></subj-group></article-categories><title-group><article-title>Barrier-to-Autointegration Factor Proteome Reveals Chromatin-Regulatory Partners</article-title><alt-title alt-title-type="running-head">BAF Associated Proteins</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Montes de Oca</surname><given-names>Roc&#x000ed;o</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shoemaker</surname><given-names>Christopher J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gucek</surname><given-names>Marjan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cole</surname><given-names>Robert N.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Katherine L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Mass Spectrometry and Proteomics Facility, IBBS, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Fugmann</surname><given-names>Sebastian D.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">National Institute on Aging, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>klwilson@jhmi.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: RMdO KLW. Performed the experiments: RMdO MG. Analyzed the data: RMdO CJS MG RNC KLW. Contributed reagents/materials/analysis tools: RMdO MG RNC KLW. Wrote the paper: RMdO KLW.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>16</day><month>9</month><year>2009</year></pub-date><volume>4</volume><issue>9</issue><elocation-id>e7050</elocation-id><history><date date-type="received"><day>10</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>10</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>Montes de Oca et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Nuclear lamin filaments and associated proteins form a nucleoskeletal (&#x0201c;lamina&#x0201d;) network required for transcription, replication, chromatin organization and epigenetic regulation in metazoans. Lamina defects cause human disease (&#x0201c;laminopathies&#x0201d;) and are linked to aging. Barrier-to-autointegration factor (BAF) is a mobile and essential component of the nuclear lamina that binds directly to histones, lamins and LEM-domain proteins, including the inner nuclear membrane protein emerin, and has roles in chromatin structure, mitosis and gene regulation. To understand BAF's mechanisms of action, BAF associated proteins were affinity-purified from HeLa cell nuclear lysates using BAF-conjugated beads, and identified by tandem mass spectrometry or independently identified and quantified using the iTRAQ method. We recovered A- and B-type lamins and core histones, all known to bind BAF directly, plus four human transcription factors (Requiem, NonO, p15, LEDGF), disease-linked proteins (e.g., Huntingtin, Treacle) and several proteins and enzymes that regulate chromatin. Association with endogenous BAF was independently validated by co-immunoprecipitation from HeLa cells for seven candidates including Requiem, poly(ADP-ribose) polymerase 1 (PARP1), retinoblastoma binding protein 4 (RBBP4), damage-specific DNA binding protein 1 (DDB1) and DDB2. Interestingly, endogenous BAF and emerin each associated with DDB2 and CUL4A in a UV- and time-dependent manner, suggesting BAF and emerin have dynamic roles in genome integrity and might help couple DNA damage responses to the nuclear lamina network. We conclude this proteome is a rich source of candidate partners for BAF and potentially also A- and B-type lamins, which may reveal how chromatin regulation and genome integrity are linked to nuclear structure.</p></abstract><counts><page-count count="15"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The nuclear envelope and lamin filament networks tether chromatin and influence chromatin organization and gene expression at several levels <xref ref-type="bibr" rid="pone.0007050-Shaklai1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Guelen1">&#x0005b;2&#x0005d;</xref>, through mechanisms that remain obscure. A- and B-type lamins form separate networks of nuclear intermediate filaments, which are anchored to inner nuclear membrane (INM) proteins but also ramify throughout the nuclear interior <xref ref-type="bibr" rid="pone.0007050-Bridger1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Dorner1">&#x0005b;4&#x0005d;</xref>. Lamins interact with chromatin and support most nuclear activities including replication, transcription and DNA damage repair <xref ref-type="bibr" rid="pone.0007050-Shumaker1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007050-Ramirez1">&#x0005b;8&#x0005d;</xref>. Mutations in A-type lamins or other lamina components cause more than 15 human diseases (&#x0201c;laminopathies&#x0201d;) including Emery-Dreifuss muscular dystrophy and accelerated aging syndromes (i.e., atypical Werner, Hutchinson-Gilford Progeria Syndrome) <xref ref-type="bibr" rid="pone.0007050-Jacob1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Worman1">&#x0005b;10&#x0005d;</xref>. Cells expressing mutant lamins have compromised nuclear integrity. For example, in Hutchinson-Gilford progeria cells the mutated lamin A precursor (&#x0201c;progerin&#x0201d;) disrupts the levels or distribution of wildtype lamins, LEM-domain proteins, histone-modifying enzymes and histone posttranslational modifications, and also responses to DNA damage <xref ref-type="bibr" rid="pone.0007050-Shumaker1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Manju1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Scaffidi1">&#x0005b;11&#x0005d;</xref>. Another protein with essential roles in nuclear integrity is BAF, a conserved direct partner for lamins <xref ref-type="bibr" rid="pone.0007050-Holaska1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Margalit1">&#x0005b;13&#x0005d;</xref> and the LEM-domain family of nuclear proteins. All characterized members of this family, including <underline>L</underline>AP2&#x003b2;, <underline>E</underline>merin, <underline>M</underline>AN1 and Lem2/NET25 at the INM, and LAP2&#x003b1; in the nuclear interior, bind BAF via their LEM-domain, and also bind directly to lamins (reviewed by <xref ref-type="bibr" rid="pone.0007050-Wagner1">&#x0005b;14&#x0005d;</xref>). Studies in <italic>Caenorhabditis elegans</italic> and mammalian cells showed that BAF is required for the integrity of the nuclear lamina network, and in combination with LEM-domain proteins and lamins has interdependent structural roles during mitosis and nuclear assembly <xref ref-type="bibr" rid="pone.0007050-Margalit1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Haraguchi1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007050-Haraguchi2">&#x0005b;18&#x0005d;</xref>.</p><p>BAF is an abundant, highly conserved and essential protein in metazoans (reviewed by <xref ref-type="bibr" rid="pone.0007050-Margalit1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-SeguraTotten1">&#x0005b;19&#x0005d;</xref>). BAF is small (89 residues; 10 kD) but forms stable obligate dimers that can bind two dsDNA molecules <xref ref-type="bibr" rid="pone.0007050-Lee1">&#x0005b;20&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007050-Zheng1">&#x0005b;23&#x0005d;</xref>. BAF binds the dsDNA phosphate backbone, and thus has no DNA sequence specificity <xref ref-type="bibr" rid="pone.0007050-Zheng1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Bradley1">&#x0005b;24&#x0005d;</xref>. BAF dimers (henceforth, &#x0201c;BAF&#x0201d;) diffuse rapidly within living cell nuclei <xref ref-type="bibr" rid="pone.0007050-Shimi1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Margalit3">&#x0005b;26&#x0005d;</xref>. However, BAF can be immobile at specific times and locations, including anaphase when BAF localizes at telomeres, and telophase when BAF concentrates at &#x0201c;core regions&#x0201d; of decondensing chromosomes to mediate early steps in nuclear envelope and lamina assembly <xref ref-type="bibr" rid="pone.0007050-Haraguchi2">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Dechat1">&#x0005b;27&#x0005d;</xref>. In addition, BAF binds directly to nucleosome-exposed core and tail regions of histone H3 and linker histone H1 <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>, and is required for chromatin structure and function in interphase cells <xref ref-type="bibr" rid="pone.0007050-Margalit3">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-SeguraTotten2">&#x0005b;29&#x0005d;</xref>, and cell cycle progression <xref ref-type="bibr" rid="pone.0007050-Furukawa1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Haraguchi3">&#x0005b;31&#x0005d;</xref>. However, the mechanisms by which BAF influences mitosis, chromatin structure, gene expression <xref ref-type="bibr" rid="pone.0007050-Wang1">&#x0005b;32&#x0005d;</xref>, and other activities including retrovirus infection <xref ref-type="bibr" rid="pone.0007050-Jacque1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Shun1">&#x0005b;34&#x0005d;</xref> are not understood.</p><p>We hypothesized that BAF influences these various activities by associating with novel partners. To discover such partners, we used affinity purification and mass spectrometry methods to identify proteins from HeLa cell nuclear extracts that specifically associated with recombinant purified human BAF dimers. This strategy yielded several expected partners (lamins, core histones and LEM-domain protein LAP2), plus many novel candidate interactors including four human transcription factors and several proteins that modify or repair chromatin. Association with endogenous BAF was confirmed <italic>in vivo</italic> for seven of 11 candidates tested. We further report that BAF and its nuclear membrane partner emerin dynamically interact with DNA damage response proteins of the CUL4-DDB-ROC1 complex, suggesting novel roles for BAF and emerin in genome integrity.</p></sec><sec id="s2"><title>Results</title><p>To identify proteins that potentially associate with BAF we affinity-purified proteins from HeLa nuclear extracts using recombinant purified His-tagged human BAF (H<sub>6</sub>BAF) dimers bound to Ni<sup>&#x0002b;&#x0002b;</sup>-agarose beads, with agarose beads alone as controls (see <xref ref-type="sec" rid="s4">Methods</xref>). Bound proteins were eluted sequentially with buffer containing 0.3 M NaCl to remove proteins of moderate affinity, then with 1 M NaCl to elute higher-affinity partners (<xref ref-type="fig" rid="pone-0007050-g001">Figure 1A</xref>). An aliquot (10&#x00025;) of each eluate was resolved by SDS-PAGE and silver-stained for qualitative analysis. Reproducible patterns of BAF-associated bands were seen (<xref ref-type="fig" rid="pone-0007050-g001">Figure 1B</xref>; n&#x0200a;&#x0003d;&#x0200a;3). The remaining eluates (90&#x00025;) from a single experiment were digested with trypsin in solution and all detectable constituent proteins were identified by liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS). Data were analyzed using an in-house Mascot server and Scaffold software, resulting in over 70 significant, unique, and non-redundant protein &#x0201c;hits&#x0201d; (<xref ref-type="supplementary-material" rid="pone.0007050.s001">Table S1</xref>). Proteins identified by Scaffold with at least 89&#x00025; confidence in the 0.3 M or 1 M NaCl eluates from BAF-beads, and not detected in bead-only controls, are listed in <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>. <xref ref-type="table" rid="pone-0007050-t002">Table 2</xref> lists selected proteins that were detected with at least 89&#x00025; confidence in a BAF-bead eluate(s) and also in a bead-only control(s). A few proteins appear in both tables based on peptides that fit each criterion. The full (100 megabyte) searchable Scaffold dataset is available upon request. We also scaled up sample preparation, and used isobaric tagging for relative and absolute quantitation (iTRAQ) reagents to independently identify and quantify proteins that were specifically enriched on BAF-beads, relative to bead-only controls. For iTRAQ analysis, the four samples were each labeled with a different iTRAQ reagent <xref ref-type="bibr" rid="pone.0007050-Ross1">&#x0005b;35&#x0005d;</xref>. This analysis yielded many proteins with significantly enriched binding to BAF-beads, relative to bead-only controls, expressed as enrichment ratios (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>).</p><fig id="pone-0007050-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.g001</object-id><label>Figure 1</label><caption><title>Affinity purification of BAF-associated proteins from HeLa cell nuclear lysates.</title><p>(A) Schematic representation of the strategy used to purify BAF-associated proteins from HeLa cell nuclear lysates. (B) Silver-stained SDS-PAGE of input (I) proteins and proteins eluted from either Ni-beads alone (&#x02212;) or Ni-BAF beads (&#x0002b;), by sequential elution with 0.3 M NaCl, then 1 M NaCl, then 0.5&#x00025; SDS and finally 2X-SB. Shown is a representative gel (n&#x0200a;&#x0003d;&#x0200a;3), with 10&#x00025; of each sample loaded per lane. Molecular weight markers are indicated.</p></caption><graphic xlink:href="pone.0007050.g001"/></fig><table-wrap id="pone-0007050-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.t001</object-id><label>Table 1</label><caption><title>Summary of all non-redundant proteins identified in the 0.3 M and 1 M NaCl elutions of HeLa nuclear lysate proteins bound to BAF beads only.</title></caption><alternatives><graphic id="pone-0007050-t001-1" xlink:href="pone.0007050.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">GI</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Defline</td><td align="left" rowspan="1" colspan="1">Function</td><td align="left" rowspan="1" colspan="1">0.3 M no BAF</td><td align="left" rowspan="1" colspan="1">0.3 M BAF</td><td align="left" rowspan="1" colspan="1">1 M no BAF</td><td align="left" rowspan="1" colspan="1">1 M BAF</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">148529014</td><td align="left" rowspan="1" colspan="1">DDB1</td><td align="left" rowspan="1" colspan="1">Damage-specific DNA binding protein 1 (127 kD)</td><td align="left" rowspan="1" colspan="1">DNA repair (NER), ubiquitylation, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">9 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">4557515</td><td align="left" rowspan="1" colspan="1">DDB2</td><td align="left" rowspan="1" colspan="1">Damage-specific DNA binding protein 2 (48 kD)</td><td align="left" rowspan="1" colspan="1">DNA repair (NER), transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">9 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">24047226</td><td align="left" rowspan="1" colspan="1">Mi2-b/CHD4</td><td align="left" rowspan="1" colspan="1">Chromodomain helicase DNA binding protein 4 (220 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, gene expression, rRNA trasncription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">7 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1016275</td><td align="left" rowspan="1" colspan="1">RBBP4/RbAp48</td><td align="left" rowspan="1" colspan="1">Retinoblastoma-binding protein mRbAp48 (52 kD)</td><td align="left" rowspan="1" colspan="1">Histone chaperone, chrom. remodeling, transcription, Ras signal., cytosk. org.</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">108860677</td><td align="left" rowspan="1" colspan="1">MDC1</td><td align="left" rowspan="1" colspan="1">Mediator of DNA damage checkpoint 1 (235 kD)</td><td align="left" rowspan="1" colspan="1">DNA repair, cell cycle checkpoints</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109067205</td><td align="left" rowspan="1" colspan="1">HP1 gamma/CBX3</td><td align="left" rowspan="1" colspan="1">Pred: similar to chromobox homolog 3 (49 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin binding, gene silencing</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109095922</td><td align="left" rowspan="1" colspan="1">RECQL/RecQ1</td><td align="left" rowspan="1" colspan="1">Pred: similar to RecQ protein-like isoform 1 (88 kD)</td><td align="left" rowspan="1" colspan="1">DNA helicase, DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109107743</td><td align="left" rowspan="1" colspan="1">NUMA1</td><td align="left" rowspan="1" colspan="1">Pred: nuclear mitotic apparatus protein 1 isoform 3 (202 kD)</td><td align="left" rowspan="1" colspan="1">Mitotic spindle assembly</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">14211889</td><td align="left" rowspan="1" colspan="1">DPY-30 like</td><td align="left" rowspan="1" colspan="1">Dpy-30-like protein (11 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, gene expression, dosage compensation</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">109016427</td><td align="left" rowspan="1" colspan="1">GATA contain 2B</td><td align="left" rowspan="1" colspan="1">Pred: similar to GATA zinc finger domain containing 2B isoform 2 (65 kD)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">12052742</td><td align="left" rowspan="1" colspan="1">ACTL6A/BAF53a</td><td align="left" rowspan="1" colspan="1">Hypothetical protein (actin-like 6A/BAF53a)(47 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1667394</td><td align="left" rowspan="1" colspan="1">HDAC1 or HDAC2</td><td align="left" rowspan="1" colspan="1">Transcriptional regulator homolog RPD3 (55 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109081748</td><td align="left" rowspan="1" colspan="1">PKM</td><td align="left" rowspan="1" colspan="1">Pred: Pyruvate kinase 3 isoform 9 (65 kD)</td><td align="left" rowspan="1" colspan="1">Enzyme, phosphotyrosine binding protein</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109132798</td><td align="left" rowspan="1" colspan="1">Filamin alpha</td><td align="left" rowspan="1" colspan="1">Pred: filamin 1 (actin-binding protein-280) isoform 4 (281 kD)</td><td align="left" rowspan="1" colspan="1">Actin cytoskeleton, signaling, trasncription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">27529720</td><td align="left" rowspan="1" colspan="1">KIAA0670/Acinus</td><td align="left" rowspan="1" colspan="1">ACIN1 (apoptotic chromatin condensation inducer 1) homolog (146 kD)</td><td align="left" rowspan="1" colspan="1">DNA binding, apoptotic chromatin condensation</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">4885105</td><td align="left" rowspan="1" colspan="1">CAF-I p60</td><td align="left" rowspan="1" colspan="1">Chromatin assembly factor 1 subunit B (p60 subunit)(61 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription, DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.4)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109488886</td><td align="left" rowspan="1" colspan="1">HP1 beta/CBX1</td><td align="left" rowspan="1" colspan="1">Pred: similar to Chromobox protein homolog 1 (HP1 beta)(82 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin binding, gene silencing</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.2)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109105767</td><td align="left" rowspan="1" colspan="1">MTA2</td><td align="left" rowspan="1" colspan="1">Pred: similar to Metastasis-associated protein 2 (75 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.1)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109082735</td><td align="left" rowspan="1" colspan="1">hnRNP C</td><td align="left" rowspan="1" colspan="1">Pred: Heterogeneous nuclear ribonucleoprotein C (C1/C2)(34 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (98.4)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109130029</td><td align="left" rowspan="1" colspan="1">RBBP7/RbAp46</td><td align="left" rowspan="1" colspan="1">Pred: retinoblastoma binding protein 7 isoform 2, mRbAp46 (52 kD)</td><td align="left" rowspan="1" colspan="1">Histone chaperone, chromatin remodeling, transcription, Ras signaling</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (97.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109097106</td><td align="left" rowspan="1" colspan="1">SMARCC2/BAF170</td><td align="left" rowspan="1" colspan="1">Pred: SWI/SNF-related matrix-assoc'd actin-dep.regulator of chrom. C2 (114 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (92)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">28329430</td><td align="left" rowspan="1" colspan="1">Aprataxin/APTX</td><td align="left" rowspan="1" colspan="1">Aprataxin isoform b</td><td align="left" rowspan="1" colspan="1">DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">15079335</td><td align="left" rowspan="1" colspan="1">SNRPD3/SMD3</td><td align="left" rowspan="1" colspan="1">Small nuclear ribonucleoprotein D3 (14 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding, splicing activator</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109508190</td><td align="left" rowspan="1" colspan="1">LOC690956</td><td align="left" rowspan="1" colspan="1">Pred: hypothetical protein</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">178152</td><td align="left" rowspan="1" colspan="1">PARP1</td><td align="left" rowspan="1" colspan="1">Poly(ADP-ribose) polymerase (64 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription, DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109001148</td><td align="left" rowspan="1" colspan="1">HDAC1</td><td align="left" rowspan="1" colspan="1">Pred: similar to histone deacetylase 1 (54 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109116261</td><td align="left" rowspan="1" colspan="1">U5-116KD/EFTUD2</td><td align="left" rowspan="1" colspan="1">Pred: U5 snRNP-specific protein (116 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding, splicing activator</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109042322</td><td align="left" rowspan="1" colspan="1">SFRS10</td><td align="left" rowspan="1" colspan="1">Pred: similar to Splicing factor arg/ser rich 10 (32 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding, splicing activator</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">73951860</td><td align="left" rowspan="1" colspan="1">Limbin/EVC2</td><td align="left" rowspan="1" colspan="1">Pred: similar to Limbin (144 kD)</td><td align="left" rowspan="1" colspan="1">Unknown, related to skeletal development</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109070808</td><td align="left" rowspan="1" colspan="1">HMGA1</td><td align="left" rowspan="1" colspan="1">Pred: similar to High mobility group AT-hook 1 isoform 2 (20 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure, transcription, viral integration (HIV-1)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">18644883</td><td align="left" rowspan="1" colspan="1">ATP5J</td><td align="left" rowspan="1" colspan="1">ATP synthase F0 complex subunit F6, H&#x0002b; transporting (13 kD)</td><td align="left" rowspan="1" colspan="1">ATP synthase structure, H&#x0002b; transport</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">27436951</td><td align="left" rowspan="1" colspan="1">Lamin B2</td><td align="left" rowspan="1" colspan="1">Lamin B2 (68 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architecture and function, signaling, gene expression</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1711406</td><td align="left" rowspan="1" colspan="1">SMARCA2/BAF190</td><td align="left" rowspan="1" colspan="1">SWI/SNF-related matrix-assoc'd actin-dep.regulator of chrom. A2 (SNF2L2;181 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">293686</td><td align="left" rowspan="1" colspan="1">Keratin 6A</td><td align="left" rowspan="1" colspan="1">Epidermal keratin subunit II (59 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109504651</td><td align="left" rowspan="1" colspan="1">XP_573984</td><td align="left" rowspan="1" colspan="1">Pred: hypothetical protein (31 kD)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">156142197</td><td align="left" rowspan="1" colspan="1">G9a</td><td align="left" rowspan="1" colspan="1">Euchromatic histone-lysine N-methyltransferase 2 isoform a (EHMT2)(132 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109076878</td><td align="left" rowspan="1" colspan="1">p15/SUB1/PC4</td><td align="left" rowspan="1" colspan="1">Pred: similar to Activated RNAP II transcriptional coactivator p15 (19 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin remodeling, transcription (e.g., p53 gene), DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109128201</td><td align="left" rowspan="1" colspan="1">CD2BP2</td><td align="left" rowspan="1" colspan="1">Pred: CD2 antigen (cytoplasmic tail) binding protein 2 isoform 1 (37 kD)</td><td align="left" rowspan="1" colspan="1">Splicing, signaling</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1083466</td><td align="left" rowspan="1" colspan="1">Requiem</td><td align="left" rowspan="1" colspan="1">Probable transcription factor requiem (42 kD)</td><td align="left" rowspan="1" colspan="1">Transcription factor, apoptosis</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">74136411</td><td align="left" rowspan="1" colspan="1">PAEP</td><td align="left" rowspan="1" colspan="1">Glycodelin, progesterone associated endometrial protein (21 kD)</td><td align="left" rowspan="1" colspan="1">Secreted protein</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">88953904</td><td align="left" rowspan="1" colspan="1">BAF/BANF1</td><td align="left" rowspan="1" colspan="1">Pred: similar to barrier-to-autointegration factor (10 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architect. &#x00026; funct., chrom. org., gene express., viral integrat.</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">108935957</td><td align="left" rowspan="1" colspan="1">BCL7C</td><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 7 protein family member C (23 kD)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109111495</td><td align="left" rowspan="1" colspan="1">LEDGF/p75</td><td align="left" rowspan="1" colspan="1">Pred: similar to PC4 and SFRS1 interacting protein 1 isoform 2</td><td align="left" rowspan="1" colspan="1">Transcriptional activator, mRNA splicing, viral integration (HIV-1)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">124339826</td><td align="left" rowspan="1" colspan="1">Hsp70/HSPA1B</td><td align="left" rowspan="1" colspan="1">Heat shock 70 kDa protein 1B (70 kD)</td><td align="left" rowspan="1" colspan="1">Chaperone, stress response</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">115495195</td><td align="left" rowspan="1" colspan="1">Tektin 1</td><td align="left" rowspan="1" colspan="1">Tektin 1 (49 kD)</td><td align="left" rowspan="1" colspan="1">Structural, filament-forming protein localized in cilia and flagella</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">28279079</td><td align="left" rowspan="1" colspan="1">ZNF428</td><td align="left" rowspan="1" colspan="1">Zinc finger protein 428</td><td align="left" rowspan="1" colspan="1">DNA binding</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1942991</td><td align="left" rowspan="1" colspan="1">Cyt C oxidase</td><td align="left" rowspan="1" colspan="1">Cytochrome C oxidase, Chain F (11 kD)</td><td align="left" rowspan="1" colspan="1">Electron transfer, metabolism</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">74220835</td><td align="left" rowspan="1" colspan="1">Lamin A/C</td><td align="left" rowspan="1" colspan="1">Unnamed protein product; lamin A/C (65 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architecture and function, signaling, gene expression</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109074343</td><td align="left" rowspan="1" colspan="1">hnRNP D0/AUF1</td><td align="left" rowspan="1" colspan="1">Pred: similar to Heterogeneous nuclear ribonucleoprotein D0 (31 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding, mRNA degradation</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">10181166</td><td align="left" rowspan="1" colspan="1">SMARCE1/BAF57</td><td align="left" rowspan="1" colspan="1">SWI/SNF related, matrix assoc'd, actin dep. regulator of chromatin E1 (47 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">74207672</td><td align="left" rowspan="1" colspan="1">H2A</td><td align="left" rowspan="1" colspan="1">Unnamed protein product; putative H2A protein (14 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">1195531</td><td align="left" rowspan="1" colspan="1">Keratin 16</td><td align="left" rowspan="1" colspan="1">Type I keratin 16</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">6 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109096781</td><td align="left" rowspan="1" colspan="1">Keratin 6A</td><td align="left" rowspan="1" colspan="1">Pred: keratin 6A isoform 18</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">1722884</td><td align="left" rowspan="1" colspan="1">XPC/XPCC</td><td align="left" rowspan="1" colspan="1">DNA-repair protein, Xeroderma pigmentosum group C (106 kD)</td><td align="left" rowspan="1" colspan="1">DNA repair (NER)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109096823</td><td align="left" rowspan="1" colspan="1">Keratin 1</td><td align="left" rowspan="1" colspan="1">Pred: similar to keratin 1 isoform 7</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">1147813</td><td align="left" rowspan="1" colspan="1">Desmoplakin I</td><td align="left" rowspan="1" colspan="1">Desmoplakin I (DSP)</td><td align="left" rowspan="1" colspan="1">Cell-cell comunication (desmosomes), structural</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (96.6)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Non-redundant protein hits for H<sub>6</sub>BAF-conjugated versus empty-control Ni-beads, eluted sequentially with 0.3 and 1 M NaCl, and identified with at least 89&#x00025; confidence by Scaffold software. Columns labeled 0.3 M no BAF, 0.3 M BAF, 1 M no BAF and 1 M BAF indicate the number of unique peptides identified per elution, with the &#x00025; confidence per each protein identified in brackets ( ). Abbreviations: GI, NCBI protein accession number; Defline, definition line/expanded description, plus predicted molecular weight by scaffold software in brackets ( ).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0007050-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.t002</object-id><label>Table 2</label><caption><title>Summary of all non-redundant proteins identified in the 0.3 M and 1 M NaCl elutions of HeLa nuclear lysate proteins bound to BAF and control beads.</title></caption><alternatives><graphic id="pone-0007050-t002-2" xlink:href="pone.0007050.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">GI</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Defline</td><td align="left" rowspan="1" colspan="1">Function</td><td align="left" rowspan="1" colspan="1">0.3 M no BAF</td><td align="left" rowspan="1" colspan="1">0.3 M BAF</td><td align="left" rowspan="1" colspan="1">1 M no BAF</td><td align="left" rowspan="1" colspan="1">1 M BAF</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">156523968</td><td align="left" rowspan="1" colspan="1">PARP1</td><td align="left" rowspan="1" colspan="1">Poly(ADP-ribose) polymerase family, member 1 (113 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin structure and remodeling, transcription, DNA repair</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">31 (100)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">11 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">27436946</td><td align="left" rowspan="1" colspan="1">Lamin A/C</td><td align="left" rowspan="1" colspan="1">Lamin A/C isoform 1, (70 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architecture and function, signaling, gene expression</td><td align="left" rowspan="1" colspan="1">24 (100)</td><td align="left" rowspan="1" colspan="1">25 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">12 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109101818</td><td align="left" rowspan="1" colspan="1">Nucleolin</td><td align="left" rowspan="1" colspan="1">Pred: similar to nucleolin (101 kD)</td><td align="left" rowspan="1" colspan="1">Ribosome biogenesis, cell growth and proliferation, chromatin org.</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">10 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">2 (99)</td></tr><tr><td align="left" rowspan="1" colspan="1">11935049</td><td align="left" rowspan="1" colspan="1">Keratin 1</td><td align="left" rowspan="1" colspan="1">Keratin 1 (66 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">17 (100)</td><td align="left" rowspan="1" colspan="1">9 (100)</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">16 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">5031877</td><td align="left" rowspan="1" colspan="1">Lamin B1</td><td align="left" rowspan="1" colspan="1">Lamin B1 (66 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architecture and function, signaling, gene expression</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">8 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (97.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">10120888</td><td align="left" rowspan="1" colspan="1">BAF/BANF1</td><td align="left" rowspan="1" colspan="1">Breakpoint cluster region protein 1; barrier to autointegration factor 1 (10 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architect. and function, chrom. org., gene expression, viral integrat.</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">7 (100)</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">55956899</td><td align="left" rowspan="1" colspan="1">Keratin 9</td><td align="left" rowspan="1" colspan="1">Keratin 9 (62 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">8 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109096963</td><td align="left" rowspan="1" colspan="1">HP1 alpha/CBX5</td><td align="left" rowspan="1" colspan="1">Pred: Chromobox protein homolog 5 (HP1alpha)(32 kD)</td><td align="left" rowspan="1" colspan="1">Chromatin binding, gene silencing</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">21961605</td><td align="left" rowspan="1" colspan="1">Keratin 10</td><td align="left" rowspan="1" colspan="1">Keratin 10 (59 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">8 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">7 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109112233</td><td align="left" rowspan="1" colspan="1">Hsp70</td><td align="left" rowspan="1" colspan="1">Pred: heat shock 70 kDa protein 5 (glucose-regulated protein) isoform 1 (78 kD)</td><td align="left" rowspan="1" colspan="1">Chaperone, stress response</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">74003971</td><td align="left" rowspan="1" colspan="1">H2A</td><td align="left" rowspan="1" colspan="1">Pred: similar to histone 1, H2ai isoform 1 (29 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">7 (100)</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">20336746</td><td align="left" rowspan="1" colspan="1">macro H2A</td><td align="left" rowspan="1" colspan="1">H2A histone family, member Y isoform 1 (39 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function (X inactivation)</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109504921</td><td align="left" rowspan="1" colspan="1">H4</td><td align="left" rowspan="1" colspan="1">Pred: similar to germinal histone H4 (11 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">6 (100)</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109098344</td><td align="left" rowspan="1" colspan="1">TMPO/LAP2</td><td align="left" rowspan="1" colspan="1">Pred: Thymopoietin isoform 2 (LAP2)(75 kD)</td><td align="left" rowspan="1" colspan="1">Nuclear architecture and function, signaling</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">4 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">10835063</td><td align="left" rowspan="1" colspan="1">Nucleophosmin</td><td align="left" rowspan="1" colspan="1">Nucleophosmin 1 isoform 1 (33 kD)</td><td align="left" rowspan="1" colspan="1">Ribosome biogenesis, cell growth and proliferation, chromatin org.</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">5 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109492380</td><td align="left" rowspan="1" colspan="1">Actin</td><td align="left" rowspan="1" colspan="1">Pred: similar to Actin, cytoplasmic 2 (Gamma-actin)(59 kD)</td><td align="left" rowspan="1" colspan="1">Structural, chromatin remodeling, transcription</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">3 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">47132620</td><td align="left" rowspan="1" colspan="1">Keratin 2</td><td align="left" rowspan="1" colspan="1">Keratin 2 (65 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">12653493</td><td align="left" rowspan="1" colspan="1">BASP1/NAP22</td><td align="left" rowspan="1" colspan="1">Brain abundant, membrane attached signal protein 1 (23 kD)</td><td align="left" rowspan="1" colspan="1">Nerve cell morphology, gene expression</td><td align="left" rowspan="1" colspan="1">2 (99.4)</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">2 (99.5)</td><td align="left" rowspan="1" colspan="1">2 (99.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">109066680</td><td align="left" rowspan="1" colspan="1">H2A</td><td align="left" rowspan="1" colspan="1">Pred: similar to H2A histone family, member V isoform 1 (33 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">3 (99.8)</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">109464859</td><td align="left" rowspan="1" colspan="1">Hsp70</td><td align="left" rowspan="1" colspan="1">Pred: similar to heat shock protein 8 (70 kD)</td><td align="left" rowspan="1" colspan="1">Chaperone, stress response</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109071712</td><td align="left" rowspan="1" colspan="1">eEF1A 1</td><td align="left" rowspan="1" colspan="1">Pred: similar to eukaryotic translation elongation factor 1 alpha 1 isoform 4 (48 kD)</td><td align="left" rowspan="1" colspan="1">Protein synthesis</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">121903</td><td align="left" rowspan="1" colspan="1">H1.1 or H1.2</td><td align="left" rowspan="1" colspan="1">Histone H1.1, H1.2 (10 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">225632</td><td align="left" rowspan="1" colspan="1">Casein</td><td align="left" rowspan="1" colspan="1">Casein alphaS1 (24 kD)</td><td align="left" rowspan="1" colspan="1">Secreted protein</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109003367</td><td align="left" rowspan="1" colspan="1">EFIA/NSEP1/YB-1</td><td align="left" rowspan="1" colspan="1">Pred: similar to nuclease sensitive element binding protein 1 (49 kD)</td><td align="left" rowspan="1" colspan="1">DNA binding, gene expression</td><td align="left" rowspan="1" colspan="1">2 (97.7)</td><td align="left" rowspan="1" colspan="1">2 (99.1)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109114623</td><td align="left" rowspan="1" colspan="1">ASF/SF2/SFRS1</td><td align="left" rowspan="1" colspan="1">Pred: similar to splicing factor, arginine/serine-rich 1 (ASF/SF2)(45 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding and splicing, genome stability, cell viability, viral splicing (HIV-1)</td><td align="left" rowspan="1" colspan="1">5 (100)</td><td align="left" rowspan="1" colspan="1">2 (98.1)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109070064</td><td align="left" rowspan="1" colspan="1">H1.5</td><td align="left" rowspan="1" colspan="1">Pred: similar to Histone H1.5 (H1a)(23 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">3 (100)</td><td align="left" rowspan="1" colspan="1">2 (94.3)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">2 (98.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">157823451</td><td align="left" rowspan="1" colspan="1">RBMX/Rbmxrt</td><td align="left" rowspan="1" colspan="1">RNA binding motif protein, X chromosome retrogene-like (42 kD)</td><td align="left" rowspan="1" colspan="1">RNA binding, splicing activator</td><td align="left" rowspan="1" colspan="1">4 (100)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109121665</td><td align="left" rowspan="1" colspan="1">Myosin/MRCL2</td><td align="left" rowspan="1" colspan="1">Pred: similar to Myosin regulatory light chain 2, nonsarcomeric (20 kD)</td><td align="left" rowspan="1" colspan="1">Actin binding, stress fiber organization</td><td align="left" rowspan="1" colspan="1">3 (99.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">109067280</td><td align="left" rowspan="1" colspan="1">Myosin/MLC6</td><td align="left" rowspan="1" colspan="1">Pred: similar to Myosin light polypeptide 6 (17 kD)</td><td align="left" rowspan="1" colspan="1">Motor protein</td><td align="left" rowspan="1" colspan="1">2 (99.6)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">2 (99.2)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">12803709</td><td align="left" rowspan="1" colspan="1">Keratin 14</td><td align="left" rowspan="1" colspan="1">Keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner)(52 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">2 (98.9)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">13 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">16418453</td><td align="left" rowspan="1" colspan="1">Pannexin 3</td><td align="left" rowspan="1" colspan="1">Pannexin 3, putative gap junction protein pannexin 3 (45 kD)</td><td align="left" rowspan="1" colspan="1">Cell-cell comunication (cell type-specific gap junctions)</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">126165296</td><td align="left" rowspan="1" colspan="1">H2B</td><td align="left" rowspan="1" colspan="1">Histone cluster 1, H2bn (14 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">10645195</td><td align="left" rowspan="1" colspan="1">H2A</td><td align="left" rowspan="1" colspan="1">Histone cluster 1, H2ae (14 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">12653649</td><td align="left" rowspan="1" colspan="1">RPL14</td><td align="left" rowspan="1" colspan="1">Ribosomal protein L14 (24 kD)</td><td align="left" rowspan="1" colspan="1">Ribosome biogenesis</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">41946811</td><td align="left" rowspan="1" colspan="1">SNRPF/snRNP F</td><td align="left" rowspan="1" colspan="1">Snrpf protein, small nuclear ribonucleoprotein polypeptide F (12 kD)</td><td align="left" rowspan="1" colspan="1">snRNPs biogenesis, RNA splicing</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">57110429</td><td align="left" rowspan="1" colspan="1">H1.5</td><td align="left" rowspan="1" colspan="1">Pred: similar to Histone H1.5 (H1a)(22 kD)</td><td align="left" rowspan="1" colspan="1">Nucleosomes, chromatin organization and function</td><td align="left" rowspan="1" colspan="1">1 (90.8)</td><td align="left" rowspan="1" colspan="1">1 (89.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">6005757</td><td align="left" rowspan="1" colspan="1">SPT16/FACTp140</td><td align="left" rowspan="1" colspan="1">Chromatin-specific transcription elongation factor large subunit (120 kD)</td><td align="left" rowspan="1" colspan="1">Replication, transcription, nucleosome disassembly, H2AX exchange factor</td><td align="left" rowspan="1" colspan="1">3 (99.9)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">6 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109096789</td><td align="left" rowspan="1" colspan="1">Keratin 5</td><td align="left" rowspan="1" colspan="1">Pred: keratin 5 isoform 15 (63 kD)</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">3 (99.8)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 (91.8)</td><td align="left" rowspan="1" colspan="1">11 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">21754583</td><td align="left" rowspan="1" colspan="1">Keratin</td><td align="left" rowspan="1" colspan="1">Unnamed protein product; similar to keratin</td><td align="left" rowspan="1" colspan="1">Structural</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">109106294</td><td align="left" rowspan="1" colspan="1">SSRP1/FACTp80</td><td align="left" rowspan="1" colspan="1">Pred: similar to structure specific recognition protein 1 (81 kD)</td><td align="left" rowspan="1" colspan="1">Replication, transcription, nucleosome disassembly, H2AX exchange factor</td><td align="left" rowspan="1" colspan="1">2 (98)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (99.8)</td><td align="left" rowspan="1" colspan="1">3 (100)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p>Non-redundant protein hits for H<sub>6</sub>BAF-conjugated versus empty-control Ni-beads, eluted sequentially with 0.3 and 1 M NaCl, and identified with at least 89&#x00025; confidence by Scaffold software. Columns labeled 0.3 M no BAF, 0.3 M BAF, 1 M no BAF and 1 M BAF indicate the number of unique peptides identified per elution, with the &#x00025; confidence per each protein identified in brackets ( ). Abbreviations: GI, NCBI protein accession number; Defline, definition line/expanded description, plus predicted molecular weight by scaffold software in brackets ( ).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0007050-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.t003</object-id><label>Table 3</label><caption><title>iTRAQ quantification of bound proteins eluted by 0.3 M or 1.0 M NaCl from BAF beads, relative to bead-only controls.</title></caption><alternatives><graphic id="pone-0007050-t003-3" xlink:href="pone.0007050.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Score</td><td align="left" rowspan="1" colspan="1">&#x00025; Cov</td><td align="left" rowspan="1" colspan="1">GI</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Description</td><td align="left" rowspan="1" colspan="1">0.3 M/control</td><td align="left" rowspan="1" colspan="1">1M/0.3 M</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">59.9</td><td align="left" rowspan="1" colspan="1">56.2</td><td align="left" rowspan="1" colspan="1">125962</td><td align="left" rowspan="1" colspan="1">LMNA_HUMAN</td><td align="left" rowspan="1" colspan="1">Lamin-A/C (70 kDa lamin)</td><td align="left" rowspan="1" colspan="1">11.1</td><td align="left" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">18.6</td><td align="left" rowspan="1" colspan="1">44.2</td><td align="left" rowspan="1" colspan="1">136429</td><td align="left" rowspan="1" colspan="1">TRYP_PIG</td><td align="left" rowspan="1" colspan="1">Trypsin precursor</td><td align="left" rowspan="1" colspan="1">1.1</td><td align="left" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" rowspan="1" colspan="1">14.9</td><td align="left" rowspan="1" colspan="1">94.4</td><td align="left" rowspan="1" colspan="1">71152308</td><td align="left" rowspan="1" colspan="1">BAF_PONPY</td><td align="left" rowspan="1" colspan="1">Barrier-to-autointegration factor</td><td align="left" rowspan="1" colspan="1">19.1</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">10.9</td><td align="left" rowspan="1" colspan="1">41.2</td><td align="left" rowspan="1" colspan="1">114762</td><td align="left" rowspan="1" colspan="1">NPM_HUMAN</td><td align="left" rowspan="1" colspan="1">Nucleophosmin (NPM)</td><td align="left" rowspan="1" colspan="1">15.9</td><td align="left" rowspan="1" colspan="1">2.6</td></tr><tr><td align="left" rowspan="1" colspan="1">7.2</td><td align="left" rowspan="1" colspan="1">73.8</td><td align="left" rowspan="1" colspan="1">81884120</td><td align="left" rowspan="1" colspan="1">H2B1H_MOUSE</td><td align="left" rowspan="1" colspan="1">Histone H2B</td><td align="left" rowspan="1" colspan="1">10.8</td><td align="left" rowspan="1" colspan="1">3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">6.9</td><td align="left" rowspan="1" colspan="1">19.9</td><td align="left" rowspan="1" colspan="1">1709851</td><td align="left" rowspan="1" colspan="1">SFPQ_HUMAN</td><td align="left" rowspan="1" colspan="1">Splicing factor, proline- and glutamine-rich</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">23.7</td><td align="left" rowspan="1" colspan="1">1168325</td><td align="left" rowspan="1" colspan="1">ACT5_BACDO</td><td align="left" rowspan="1" colspan="1">Actin</td><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">4.4</td><td align="left" rowspan="1" colspan="1">21.1</td><td align="left" rowspan="1" colspan="1">46396655</td><td align="left" rowspan="1" colspan="1">SET_MOUSE</td><td align="left" rowspan="1" colspan="1">SET (Protein Phosphatase 2A inhibitor, I2PP2A)</td><td align="left" rowspan="1" colspan="1">20.6</td><td align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">4.0</td><td align="left" rowspan="1" colspan="1">10.7</td><td align="left" rowspan="1" colspan="1">38257560</td><td align="left" rowspan="1" colspan="1">FLNA_MOUSE</td><td align="left" rowspan="1" colspan="1">Filamin-A</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">4.0</td><td align="left" rowspan="1" colspan="1">22.1</td><td align="left" rowspan="1" colspan="1">67460593</td><td align="left" rowspan="1" colspan="1">NONO_RAT</td><td align="left" rowspan="1" colspan="1">NonO protein</td><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">34.0</td><td align="left" rowspan="1" colspan="1">51315709</td><td align="left" rowspan="1" colspan="1">H4_MYTCH</td><td align="left" rowspan="1" colspan="1">Histone H4</td><td align="left" rowspan="1" colspan="1">10.7</td><td align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">35.3</td><td align="left" rowspan="1" colspan="1">73919839</td><td align="left" rowspan="1" colspan="1">H33_VITVI</td><td align="left" rowspan="1" colspan="1">Histone H3.3</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1">13.4</td><td align="left" rowspan="1" colspan="1">133274</td><td align="left" rowspan="1" colspan="1">HNRPL_HUMAN</td><td align="left" rowspan="1" colspan="1">Heterogeneous nuclear ribonucleoprotein L (hnRNP L)</td><td align="left" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1">40.4</td><td align="left" rowspan="1" colspan="1">75277395</td><td align="left" rowspan="1" colspan="1">H2AV1_ARATH</td><td align="left" rowspan="1" colspan="1">Histone H2A</td><td align="left" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1">4.0</td></tr><tr><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">32.4</td><td align="left" rowspan="1" colspan="1">417101</td><td align="left" rowspan="1" colspan="1">H12_HUMAN</td><td align="left" rowspan="1" colspan="1">Histone H1.2</td><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">2.5</td><td align="left" rowspan="1" colspan="1">11.7</td><td align="left" rowspan="1" colspan="1">1730009</td><td align="left" rowspan="1" colspan="1">TPR_HUMAN</td><td align="left" rowspan="1" colspan="1">Nucleoprotein TPR</td><td align="left" rowspan="1" colspan="1">3.6</td><td align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">2.1</td><td align="left" rowspan="1" colspan="1">17.1</td><td align="left" rowspan="1" colspan="1">26390818</td><td align="left" rowspan="1" colspan="1">AN32B_HUMAN</td><td align="left" rowspan="1" colspan="1">Acidic leucine-rich nuclear phosphoprotein (PHAPI2)</td><td align="left" rowspan="1" colspan="1">6.7</td><td align="left" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">2.1</td><td align="left" rowspan="1" colspan="1">9.9</td><td align="left" rowspan="1" colspan="1">61214649</td><td align="left" rowspan="1" colspan="1">PP1RA_PIG</td><td align="left" rowspan="1" colspan="1">Serine/threonine-protein phosphatase 1 (FB19)</td><td align="left" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">8.6</td><td align="left" rowspan="1" colspan="1">1708162</td><td align="left" rowspan="1" colspan="1">HD_RAT</td><td align="left" rowspan="1" colspan="1">Huntingtin (Huntington disease protein)</td><td align="left" rowspan="1" colspan="1">15.0</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">8.4</td><td align="left" rowspan="1" colspan="1">40739534</td><td align="left" rowspan="1" colspan="1">KLPA_EMENI</td><td align="left" rowspan="1" colspan="1">Kinesin-like protein klpA</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">17.7</td><td align="left" rowspan="1" colspan="1">90110023</td><td align="left" rowspan="1" colspan="1">H2AY_HUMAN</td><td align="left" rowspan="1" colspan="1">Core histone macro-H2A (inactive X chromosome)</td><td align="left" rowspan="1" colspan="1">13.5</td><td align="left" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">9.2</td><td align="left" rowspan="1" colspan="1">82236756</td><td align="left" rowspan="1" colspan="1">RBP4B_XENLA</td><td align="left" rowspan="1" colspan="1">Histone-binding protein RBBP4/7</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">12.8</td><td align="left" rowspan="1" colspan="1">71162379</td><td align="left" rowspan="1" colspan="1">SLYD_SHIFL</td><td align="left" rowspan="1" colspan="1">FKBP-type peptidyl-prolyl cis-trans isomerase slyD</td><td align="left" rowspan="1" colspan="1">49.6</td><td align="left" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1">16.1</td><td align="left" rowspan="1" colspan="1">547754</td><td align="left" rowspan="1" colspan="1">K22E_HUMAN</td><td align="left" rowspan="1" colspan="1">Keratin</td><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1">12.6</td><td align="left" rowspan="1" colspan="1">12229941</td><td align="left" rowspan="1" colspan="1">PSA5_SCHPO</td><td align="left" rowspan="1" colspan="1">Probable proteasome subunit alpha type 5</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">1.4</td><td align="left" rowspan="1" colspan="1">8.7</td><td align="left" rowspan="1" colspan="1">6685905</td><td align="left" rowspan="1" colspan="1">RPOC2_ARATH</td><td align="left" rowspan="1" colspan="1">DNA-directed RNA polymerase beta chain</td><td align="left" rowspan="1" colspan="1">43.4</td><td align="left" rowspan="1" colspan="1">1.1</td></tr><tr><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">11.6</td><td align="left" rowspan="1" colspan="1">122066350</td><td align="left" rowspan="1" colspan="1">TCOF_HUMAN</td><td align="left" rowspan="1" colspan="1">Treacle protein (Treacher Collins syndrome protein)</td><td align="left" rowspan="1" colspan="1">14.5</td><td align="left" rowspan="1" colspan="1">3.2</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>Abbreviations: Score, protein pilot score (2 pts per unique 99&#x00025; confidence peptide, 1 pt per unique 95&#x00025; confidence peptide); &#x00025; Cov, percent peptide coverage of identified protein; GI, NCBI protein accession number; 0.3 M, 0.3 M NaCl eluate; 1 M, 1.0 M NaCl eluate.</p></fn></table-wrap-foot></table-wrap><p>The iTRAQ analysis (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>) yielded several abundant proteins known to bind BAF directly, including lamin A <xref ref-type="bibr" rid="pone.0007050-Holaska1">&#x0005b;12&#x0005d;</xref>, core histones H3 and H4 <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>, plus one protein, histone H1.2, known to associate with BAF indirectly <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>. All detected proteins were present in both the 0.3 and 1 M BAF-bead eluates (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>; 1 M/0.3 M column). Several proteins including H2A, H2B and Treacle were enriched 3&#x02013;4 fold in the 1 M eluate, compared to the 0.3 M eluate (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>; 1 M/0.3 M column), suggesting relatively high affinity either for BAF or a co-purified partner (e.g., lamin A or histone H3 <xref ref-type="bibr" rid="pone.0007050-Holaska1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>). The iTRAQ results for the 0.3 M eluates showed that lamin A/C and all four core histones were enriched on BAF-beads (over control beads) by &#x0223c;11-fold and 8.8-to-10.8-fold, respectively (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>; 0.3 M/control column). Similar enrichments for individual core histones implied similar stoichiometry and suggested they bound BAF as nucleosomes. This was consistent with evidence that BAF binds core histone H3 <italic>in vitro</italic> and <italic>in vivo</italic><xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref> and associates with nucleosomes <italic>in vivo</italic> (Montes de Oca, Andreassen &#x00026; Wilson, in preparation). Alternatively, core histones might co-enrich on BAF-beads by binding other abundantly recovered proteins including lamins (via H2A/H2B; <xref ref-type="bibr" rid="pone.0007050-Goldberg1">&#x0005b;36&#x0005d;</xref>) or PARP1 <xref ref-type="bibr" rid="pone.0007050-Kim1">&#x0005b;37&#x0005d;</xref>. Histone macro-H2A, which concentrates on the inactive X-chromosome <xref ref-type="bibr" rid="pone.0007050-Costanzi1">&#x0005b;38&#x0005d;</xref>, was enriched 13.5-fold (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>, 0.3/control column). Compared to controls, the iTRAQ analysis (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>) also revealed significant enrichment for nucleophosmin (&#x0223c;16-fold), SET/I2PP2A (&#x0223c;21-fold), transcription factor NonO (&#x0223c;3-fold), Ser/Thr-protein phosphatase 1 (FB19; &#x0223c;3-fold), Huntingtin (15-fold), RBBP4 and/or RBBP7 (&#x0223c;4-fold; see also <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), FKBP-type peptidyl-prolyl cis-trans isomerase slyD (&#x0223c;50-fold), DNA-directed RNA polymerase beta (&#x0223c;43-fold) and Treacle (Treacher-Collins Syndrome protein; &#x0223c;14-fold).</p><p>Additional candidates were independently identified by LC-MS/MS (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>) including three transcription factors (Requiem, p15/SUB1/PC4 and LEDGF/p75 &#x0005b;<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>&#x0005d;) and a remarkable number of proteins involved in gene regulation or genome integrity including PARP1 (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>), DDB1 and DDB2 (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) and Xeroderma pigmentosum complementation group C protein (XPC/XPCC; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>). Also recovered were Mediator of DNA damage Checkpoint 1 protein (MDC1; which associates with phosphorylated H2AX &#x0005b;&#x003b3;H2AX&#x0005d; and Mre11 at sites of DNA damage <xref ref-type="bibr" rid="pone.0007050-Goldberg2">&#x0005b;39&#x0005d;</xref>; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), and five components of the nucleosome remodeling and histone deacetylase (NuRD) complex: unique components MTA2 and Mi2&#x003b2;/CHD4 <xref ref-type="bibr" rid="pone.0007050-Zhang1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Zhang2">&#x0005b;41&#x0005d;</xref> (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) plus HDAC1 or HDAC2 (unique peptides not recovered; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), and RBBP4 and RBBP7 (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>, <xref ref-type="table" rid="pone-0007050-t003">3</xref>). Also identified were DPY-30-like protein (a component of Set1 histone methyltransferase complexes <xref ref-type="bibr" rid="pone.0007050-Cho1">&#x0005b;42&#x0005d;</xref>; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), G9a (an H3-K9 histone methyltransferase <xref ref-type="bibr" rid="pone.0007050-Tachibana1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Collins1">&#x0005b;44&#x0005d;</xref>; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) and three isoforms of heterochromatin protein 1 (HP1&#x003b1;, HP1&#x003b2;, HP1&#x003b3;; <xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>), which specifically recognize and bind K9-methylated H3 <xref ref-type="bibr" rid="pone.0007050-Bannister1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Jacobs1">&#x0005b;46&#x0005d;</xref>.</p><sec id="s2a"><title>Independent validation of selected candidates</title><p>To evaluate the physiological relevance of this proteome, we chose 11 candidates to test independently for potential association with BAF <italic>in vivo</italic>. Antibodies for many candidates were unavailable or unsuitable for immunoprecipitation, so we used an epitope-tag strategy. Each candidate was transiently expressed as a FLAG- or GFP-tagged protein in HeLa cells, then immunoprecipitated from whole cell lysates using antibodies against the epitope tag, resolved by SDS-PAGE and western blotted using antibodies specific for either the tag, endogenous BAF or other endogenous proteins (<xref ref-type="fig" rid="pone-0007050-g002">Figures 2</xref>, <xref ref-type="fig" rid="pone-0007050-g003">3</xref>, <xref ref-type="fig" rid="pone-0007050-g004">4</xref>). Compared to the positive and negative controls (FLAG-H3.1 and FLAG vector, respectively), BAF co-precipitated reproducibly with G9a and SET/I2PP2A (Montes de Oca, Andreassen &#x00026; Wilson, in preparation) and five other candidates including Requiem (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2A</xref>) and PARP1 (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>), as detailed below. By contrast, four other candidates associated with BAF undetectably or weakly, under the same immunoprecipitation conditions: Mi2&#x003b2; and MTA2 (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2C</xref>, lanes 1 and 2 <italic>vs</italic> 3 and 4; n&#x0200a;&#x0003d;&#x0200a;3), HDAC1 (data not shown) and DPY-30-like (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2D</xref>, lane 6 <italic>vs</italic> 2, &#x003b1;BAF; n&#x0003e;4).</p><fig id="pone-0007050-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.g002</object-id><label>Figure 2</label><caption><title>BAF associates with Requiem and PARP1 <italic>in vivo</italic>.</title><p>Western blot analysis of immunoprecipitates from HeLa cells that transiently expressed either FLAG-Requiem (A), FLAG-PARP1 (B), FLAG-Mi2&#x003b2; or FLAG-MTA2 (C), FLAG-DPY-30-like (D), FLAG-H3.1 (positive control) or FLAG vector alone (negative control). Samples were precipitated with Flag-M2 conjugated beads and eluted with 2X-SB except in (B) where bound proteins were eluted using Flag-peptide (see <xref ref-type="sec" rid="s4">Methods</xref>). Input (I, 1&#x00025;) and pellet (P, 50&#x00025;) fractions were western blotted using antibodies specific for FLAG (&#x003b1;FLAG), BAF (&#x003b1;BAF), emerin (&#x003b1;Em) or lamins A and C (&#x003b1;Lmn A/C) which migrate at 70 and 60 kD, respectively. Asterisks (&#x0002a;) indicate each transiently expressed protein. Representative results are shown for Requiem (n&#x0003e;4), PARP1 (n&#x0003e;4), Mi2&#x003b2; and MTA2 (pellets only; n&#x0200a;&#x0003d;&#x0200a;3) and DPY-30-like (n&#x0003e;4).</p></caption><graphic xlink:href="pone.0007050.g002"/></fig><fig id="pone-0007050-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.g003</object-id><label>Figure 3</label><caption><title>BAF associates efficiently with RBBP4, and weakly with RBBP7, in HeLa cells.</title><p>Western blot analysis of HeLa cells that transiently expressed GFP-RBBP4, GFP-RBBP7, GFP-H1.2 (positive control, BAF-associated <italic>in vivo</italic>) or GFP (negative control) for 24 hrs. Cells were then either left untreated (&#x02212;) or UV-irradiated (&#x0002b;), and allowed to recover for 1 hr in fresh media prior to harvest. Western blots of (A) GFP-immunoprecipitates (50&#x00025;), or (B) input whole cell lysates (0.5&#x00025;), were probed with antibodies specific for GFP (&#x003b1;GFP), BAF (&#x003b1;BAF), emerin (&#x003b1;Em) or &#x003b3;Tubulin (&#x003b1;&#x003b3;Tub; loading control). Asterisks (&#x0002a;) indicate each transiently expressed protein. Representative results are shown (n&#x0200a;&#x0003d;&#x0200a;3). (C) Aligned amino acid sequences of human RBBP4 and RBBP7, with non-identical residues shaded in gray (89.4&#x00025; identity).</p></caption><graphic xlink:href="pone.0007050.g003"/></fig><fig id="pone-0007050-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007050.g004</object-id><label>Figure 4</label><caption><title>Dynamic associations of endogenous BAF and emerin with DDB2 and CUL4A in UV-treated cells.</title><p>Western blot analysis of HeLa cells that transiently expressed FLAG-CUL4A, FLAG-DDB2, FLAG-H3.1 (positive control) or FLAG alone (negative control) for 24 hrs. Cells were either left untreated and harvested at the 1 hr timepoint (&#x02212;), or UV-irradiated and allowed to recover in fresh media for the indicated time prior to harvest. Western blots of (A) input whole cell lysates (2&#x00025; loaded) or (B) the corresponding FLAG-immunoprecipitates (50&#x00025; of controls loaded; other samples 100&#x00025; loaded), probed with antibodies specific for FLAG (&#x003b1;FLAG), BAF (&#x003b1;BAF, short and long exposures), emerin (&#x003b1;Em), DDB1 (&#x003b1;DDB1; positive control for DDB2 interaction) or PARP1 (&#x003b1;PARP1). The PARP1 antibody recognizes both full-length PARP1 (arrow) and a caspase-cleaved PARP1 fragment (arrowhead), indicative of apoptosis. Asterisks (&#x0002a;) indicate each transiently expressed FLAG-tagged protein. <xref ref-type="sec" rid="s2">Results</xref> shown are representative of at least three independent experiments.</p></caption><graphic xlink:href="pone.0007050.g004"/></fig></sec><sec id="s2b"><title>BAF associates with Requiem <italic>in vivo</italic></title><p>Requiem, with a <italic>Kruppel</italic>-type zinc finger and four atypical zinc-fingers, is a pro-apoptotic transcription factor in myeloid cells homologous to the mouse Ubi-d4 protein <xref ref-type="bibr" rid="pone.0007050-Gabig1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Wong1">&#x0005b;48&#x0005d;</xref>. FLAG-Requiem reproducibly (n&#x0003e;4) and specifically co-immunoprecipitated both endogenous BAF and endogenous emerin from cells (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2A</xref>, lane 2, &#x003b1;BAF and &#x003b1;Em). These results independently validated Requiem as BAF-associated <italic>in vivo</italic>, and further suggested potential ternary interactions with emerin. Whether BAF or emerin (or both) bind Requiem directly was not tested.</p></sec><sec id="s2c"><title>BAF associates with PARP1 in HeLa and HEK293 cells</title><p>PARP1, represented by at least 31 distinct peptides, was the most significant protein identified by LC-MS/MS (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>). PARP1 ADP-ribosylates many substrates including histones, regulates chromatin structure and has well-characterized roles in DNA damage responses <xref ref-type="bibr" rid="pone.0007050-DAmours1">&#x0005b;49&#x0005d;</xref>. We therefore independently tested a potential association between FLAG-PARP1 and endogenous BAF in HeLa cells. Controls showed little or no background pelleting of endogenous BAF with FLAG vector alone (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>, lane 4, &#x003b1;BAF), and positive co-precipitation with FLAG-H3.1 (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>, lane 6, &#x003b1;BAF), as expected. Endogenous BAF co-precipitated reproducibly and at high levels with FLAG-PARP1 under both low stringency (150 mM NaCl, 0.15&#x00025; TX-100; data not shown), and high-stringency conditions (300 mM NaCl, 0.3&#x00025; TX-100; <xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>, lane 2, &#x003b1;BAF; n&#x0003e;4). A reciprocal experiment using a stable, tetracycline-inducible FLAG-BAF overexpressing cell line (HEK293, human embryonic kidney; <xref ref-type="bibr" rid="pone.0007050-Wiebe1">&#x0005b;50&#x0005d;</xref>) gave similar results: endogenous PARP1 co-immunoprecipitated with FLAG-BAF (data not shown). Further Western blotting of the FLAG-PARP1 immunoprecipitates confirmed the presence of lamins A and C (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>, lane 2, &#x003b1;LmnA/C; n&#x0003e;4) under high stringency conditions, as expected <xref ref-type="bibr" rid="pone.0007050-Vidakovic1">&#x0005b;51&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Yusufzai1">&#x0005b;52&#x0005d;</xref>; and also revealed low levels of the nuclear membrane protein emerin (<xref ref-type="fig" rid="pone-0007050-g002">Figure 2B</xref>, lane 2, &#x003b1;Em; n&#x0003e;4), with higher signals under low stringency conditions (not shown). These results suggest BAF associates with PARP1 in two independent cell lines: HeLa and HEK293.</p></sec><sec id="s2d"><title>Selective association of BAF with RBBP4 in HeLa cells</title><p>RBBP4 (also known as Chromatin Assembly Factor-1 &#x0005b;CAF-1&#x0005d; p48 subunit or RbAp48) and RBBP7 (RbAp46) are homologous histone chaperones encoded by different genes. Both were specifically identified by LC-MS/MS (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) and at least one was identified by iTRAQ (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>). RBBP4 and RBBP7 are WD-repeat proteins that contribute, either together or separately, to several chromatin-modifying complexes including the NuRD complex <xref ref-type="bibr" rid="pone.0007050-Zhang1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Zhang2">&#x0005b;41&#x0005d;</xref> and the CAF-1 complex, required for chromatin assembly after DNA replication and repair <xref ref-type="bibr" rid="pone.0007050-Ridgway1">&#x0005b;53&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Polo1">&#x0005b;54&#x0005d;</xref>. We tested for potential interaction between endogenous BAF and either GFP-RBBP4 or GFP-RBBP7 in HeLa cells under normal conditions, or 1 hr after UV-irradiation, since RBBP4 and the CAF-1 complex mediate histone deposition during UV-damage repair. Controls confirmed little association of BAF with GFP alone (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3A</xref>, lanes 1 and 2, &#x003b1;BAF) and positive association with GFP-H1.2 (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3A</xref>, lanes 7 and 8, &#x003b1;BAF), as expected <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>. Endogenous BAF co-precipitated robustly with GFP-RBBP4 in both undamaged and UV-treated cells (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3A</xref>, lanes 3 and 4, respectively, &#x003b1;BAF; n&#x0200a;&#x0003d;&#x0200a;3). By contrast, near background levels of BAF co-precipitated with GFP-RBBP7 (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3A</xref>, lanes 5 and 6, &#x003b1;BAF; n&#x0200a;&#x0003d;&#x0200a;3). Endogenous emerin co-precipitated very weakly with both GFP-RBBP4 and GFP-RBBP7 (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3A</xref>, lanes 3&#x02013;6, &#x003b1;Em; n&#x0200a;&#x0003d;&#x0200a;3). Control Western blots of whole cell lysates verified that UV-irradiation did not significantly alter the levels of endogenous BAF or emerin proteins, relative to loading control &#x003b3;-tubulin (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3B</xref>, inputs; n&#x0200a;&#x0003d;&#x0200a;3). BAF interaction with RBBP4 was further confirmed in reciprocal studies of stable HEK293 cells with tetracycline-inducible expression of FLAG-BAF (as above): FLAG-BAF co-immunoprecipitated endogenous RBBP4 (data not shown). Thus, despite 89.4&#x00025; amino acid identity between RBBP4 and RBBP7 (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3C</xref>) <xref ref-type="bibr" rid="pone.0007050-Qian1">&#x0005b;55&#x0005d;</xref>, BAF associated robustly and selectively with RBBP4 in both untreated and UV-treated cells.</p></sec><sec id="s2e"><title>BAF and emerin interactions with DDB2 and CUL4 in UV-irradiated HeLa cells</title><p>Three proteomic candidates (DDB1, DDB2, XPC; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) are involved in DNA damage repair. DDB1 and DDB2 are key components of the UV-DNA-damage-binding protein complex (UV-DDB) <xref ref-type="bibr" rid="pone.0007050-Fujiwara1">&#x0005b;56&#x0005d;</xref>, which recognizes DNA-distorting lesions and mediates nucleotide-excision repair, in part by recruiting XPC-RAD23B heterodimers <xref ref-type="bibr" rid="pone.0007050-Moser1">&#x0005b;57&#x0005d;</xref>. In addition, DDB1 and DDB2 also associate with Cullin 4 (CUL4)-containing E3 ubiquitin ligase complexes. One such complex, CUL4-DDB-ROC1, is recruited rapidly (5&#x02013;10 min) by DDB1-DDB2 to sites of UV-induced DNA damage, where it ubiquitylates H3 and H4 causing nucleosome eviction and exposure of damaged DNA <xref ref-type="bibr" rid="pone.0007050-Wang2">&#x0005b;58&#x0005d;</xref>. The CUL4-DDB-ROC1 complex then promotes repair by recruiting repair proteins XPC and its partner RAD23B to damage sites <xref ref-type="bibr" rid="pone.0007050-Dai1">&#x0005b;59&#x0005d;</xref>.</p><p>We found that endogenous DDB1 co-immunoprecipitated with FLAG-BAF in tetracycline-induced HEK293&#x02236;BAF cells (data not shown), independently validating its association with BAF <italic>in vivo</italic>. Given the above-described roles for DDB1-DDB2 and XPC-RAD23B, and recognizing that CUL4 was not identified in our (unirradiated) HeLa cell proteome, we hypothesized that BAF might be involved in cellular responses to UV-damage. To test this idea we expressed either FLAG-CUL4A, FLAG-DDB2, FLAG-H3.1 (positive control) or FLAG vector alone (negative control) transiently (&#x0223c;24 hrs) in HeLa cells. Cells were then either treated with UV light (20 J/m<sup>2</sup>) or left untreated as controls, and allowed to recover for the indicated time. Whole cell lysates were then prepared and either Western blotted directly (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4A</xref>, inputs) or after immunoprecipitation with FLAG-conjugated beads (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, pellets). To assess whether cells were effectively damaged by UV-treatment, whole cell lysates were Western blotted with antibodies against endogenous PARP1 to assay production of its characteristic apoptosis-induced cleavage product <xref ref-type="bibr" rid="pone.0007050-DAmours2">&#x0005b;60&#x0005d;</xref>. PARP1 cleavage was weak or undetectable in untreated cells (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4A</xref>, &#x0201c;&#x02014;&#x0201d;; arrowhead), and detectable but faint 60 min after UV-treatment (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4A</xref>, lanes 2, 4, 9, 12, 14, 19; arrowhead; n&#x0200a;&#x0003d;&#x0200a;3). PARP1 cleavage was obvious 120 min after UV-treatment (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4A</xref>, lanes 10 and 20; arrowhead), suggesting cells had entered apoptosis. FLAG-pulldowns from untreated cells or from each timepoint after UV-irradiation, were probed with antibodies specific for either FLAG, endogenous DDB1, endogenous emerin or endogenous BAF (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>). Endogenous DDB1 co-precipitated with FLAG-DDB2 at all timepoints (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 5&#x02013;10, &#x003b1;DDB1; n&#x0200a;&#x0003d;&#x0200a;3) as expected, since these proteins form heterodimers <xref ref-type="bibr" rid="pone.0007050-Li1">&#x0005b;61&#x0005d;</xref>. Validating our proteomic results, endogenous BAF co-precipitated with FLAG-DDB2 (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 5&#x02013;10, &#x003b1;BAF; short and long exposures both shown; n&#x0200a;&#x0003d;&#x0200a;3) above the FLAG vector control background (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 1&#x02013;2, &#x003b1;BAF; n&#x0200a;&#x0003d;&#x0200a;3), in both UV-treated and untreated cells. Endogenous emerin also co-precipitated efficiently with FLAG-DDB2 (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 5&#x02013;10, &#x003b1;Em; n&#x0200a;&#x0003d;&#x0200a;3) in both UV-damaged and undamaged cells. In addition, emerin also co-precipitated with FLAG-CUL4A in undamaged cells, and this association transiently decreased, then increased after UV-treatment (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 15&#x02013;20, &#x003b1;Em; n&#x0200a;&#x0003d;&#x0200a;3). A similar trend was seen for the endogenous BAF association with FLAG-CUL4A (<xref ref-type="fig" rid="pone-0007050-g004">Figure 4B</xref>, lanes 15&#x02013;20, &#x003b1;BAF; n&#x0200a;&#x0003d;&#x0200a;3). Despite experiment-to-experiment variation in the exact timing of highest association between BAF or emerin and FLAG-CUL4A, endogenous BAF and emerin consistently &#x0201c;co-peaked&#x0201d; in their interaction with FLAG-CUL4A after UV-treatment. These results validated CUL4A, DDB2 and DDB1 as partners for BAF <italic>in vivo</italic>, and suggested their association with BAF is differentially regulated in response to UV-damage. Furthermore, we discovered robust and potentially UV-regulated associations of the nuclear membrane protein emerin with both DDB2 and CUL4A. These results suggest novel roles for both BAF and emerin in genome integrity.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Many pathways including transcription, replication, DNA repair, signaling and chromosome tethering require an intact nuclear lamina network <xref ref-type="bibr" rid="pone.0007050-Guelen1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Shumaker1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007050-Ramirez1">&#x0005b;8&#x0005d;</xref>. The mechanisms of this dependence are major questions in biology with relevance to aging and a spectrum of human diseases. BAF is an essential component of the nuclear lamina network, interacting with both A- and B-type lamins as well as nuclear membrane proteins and chromatin <xref ref-type="bibr" rid="pone.0007050-Margalit1">&#x0005b;13&#x0005d;</xref>. Our use of two complementary proteomic methods (LC-MS/MS and iTRAQ), and comparisons to negative controls, yielded over 70 potential interactors. Many candidates are likely to bind lamins directly, rather than BAF, and comprise a &#x0201c;lamin proteome&#x0201d; within the BAF proteome. BAF has nanomolar to low micromolar affinity for key partners (histones, LEM-domain proteins, lamins) <xref ref-type="bibr" rid="pone.0007050-Holaska1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Shumaker2">&#x0005b;62&#x0005d;</xref> and can stabilize &#x0201c;ternary&#x0201d; interactions between lamin A and emerin <xref ref-type="bibr" rid="pone.0007050-Bengtsson1">&#x0005b;63&#x0005d;</xref>. BAF-mediated stabilization of ternary complexes might account for the quantitative enrichments of lamins and histones (and potentially other candidates, e.g., SET/I2PP2A, Huntingtin) detected by iTRAQ analysis. The iTRAQ quantification was important because many nuclear proteins including LAP2, lamins and histones have been reported to bind beads nonspecifically <xref ref-type="bibr" rid="pone.0007050-TrinkleMulcahy1">&#x0005b;64&#x0005d;</xref>, and were also detected by LC-MS/MS in our control eluates (<xref ref-type="table" rid="pone-0007050-t002">Table 2</xref>). Confidence that this proteome includes novel interactors for BAF was increased by independent validation: seven of 11 tested FLAG- or GFP-tagged candidates, including single-peptide &#x0201c;hits&#x0201d; Requiem (reported here) and G9a (Montes de Oca, Andreassen &#x00026; Wilson, in preparation), co-precipitated endogenous BAF from HeLa cells. An important caveat is that these verifications were based on transient overexpression of epitope-tagged candidates, which might cause artifacts. It will be important in the future to verify the interaction between endogenous BAF and each endogenous partner.</p><sec id="s3a"><title>Other candidates</title><p>Other interesting candidates await investigation. For example the four non-skin keratins (keratins 5, 6A, 14, 16) <xref ref-type="bibr" rid="pone.0007050-Moll1">&#x0005b;65&#x0005d;</xref> identified in the high-stringency (1 M salt) BAF-bead eluate (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>) suggest that BAF, which can reside in the cytoplasm (where it mediates the innate immune response to poxvirus infection <xref ref-type="bibr" rid="pone.0007050-Wiebe1">&#x0005b;50&#x0005d;</xref>), might interact with both nuclear and cytoplasmic intermediate filaments. Other untested candidates include Huntingtin and Treacle (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>), acinus (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>; involved in internucleosomal DNA cleavage during apoptosis <xref ref-type="bibr" rid="pone.0007050-Joselin1">&#x0005b;66&#x0005d;</xref>) and MDC1 (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>; binds repair proteins and mediates DNA-damage checkpoints during S-phase <xref ref-type="bibr" rid="pone.0007050-Wu1">&#x0005b;67&#x0005d;</xref> and the G2/M transition <xref ref-type="bibr" rid="pone.0007050-Stiff1">&#x0005b;68&#x0005d;</xref>). Based on the extended S-phase observed in BAF-deficient cells <xref ref-type="bibr" rid="pone.0007050-Haraguchi3">&#x0005b;31&#x0005d;</xref> and unexplained positive roles for the LEM-domain protein LAP2 in DNA replication <xref ref-type="bibr" rid="pone.0007050-Gant1">&#x0005b;69&#x0005d;</xref>, we speculate BAF might facilitate DNA replication by influencing MDC1 or PARP1 (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>; <xref ref-type="bibr" rid="pone.0007050-Sugimura1">&#x0005b;70&#x0005d;</xref>), or by facilitating chromatin reorganization. Besides G9a (an H3-K9 methyltransferase), this proteome also included heterochromatin proteins HP1&#x003b1;, &#x003b2; and &#x003b3; (<xref ref-type="table" rid="pone-0007050-t001">Tables 1</xref>&#x02013;<xref ref-type="table" rid="pone-0007050-t002">2</xref>), which specifically bind G9a itself and K9-methylated H3 and mediate long-term silencing and heterochromatin formation <xref ref-type="bibr" rid="pone.0007050-Lachner1">&#x0005b;71&#x0005d;</xref>. We also specifically recovered four subunits of SWI/SNF complexes (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>): SMARCA2/BAF190 (also known as Brahma/BRM), and three Brahma-associated factors (regrettably, also known as BAFs): SMARCC2/BAF170, SMARCE1/BAF57 and the actin-related protein BAF53A/ACTL6A. SWI/SNF complexes are ATP-dependent chromatin remodeling complexes involved in gene expression, differentiation, proliferation and DNA repair <xref ref-type="bibr" rid="pone.0007050-Reisman1">&#x0005b;72&#x0005d;</xref>. We are unaware of any previous evidence that potentially links SWI/SNF complexes to lamins or BAF (Barrier-to-Autointegration Factor), and this will be important to test in future work.</p></sec><sec id="s3b"><title>Four human transcription factors that potentially bind BAF</title><p>BAF can regulate tissue-specific gene expression in <italic>C. elegans</italic> by binding and occupying specific promoters <xref ref-type="bibr" rid="pone.0007050-Margalit3">&#x0005b;26&#x0005d;</xref>. In mammalian retinal cells, BAF is known to bind directly to Crx and related homeodomain transcription factors and represses Crx-dependent gene activation <xref ref-type="bibr" rid="pone.0007050-Wang1">&#x0005b;32&#x0005d;</xref>. Whether BAF binds other transcription factors, or regulates specific genes in other human tissues, is largely unexplored. Our proteome identified four transcription factors (p15/SUB1/PC4, NonO, Requiem and LEDGF) with which BAF might associate in human cells. p15/SUB1/PC4 (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>; hereafter &#x0201c;PC4&#x0201d;) is an abundant nuclear protein that binds p53 and also transcriptionally co-activates p53 function <xref ref-type="bibr" rid="pone.0007050-Banerjee1">&#x0005b;73&#x0005d;</xref>. The p53 protein, in turn, activates PC4 transcription as part of a feedback loop <xref ref-type="bibr" rid="pone.0007050-Kishore1">&#x0005b;74&#x0005d;</xref>. Interestingly, PC4 also binds histones, condenses chromatin <xref ref-type="bibr" rid="pone.0007050-Das1">&#x0005b;75&#x0005d;</xref> and helps repair damaged DNA <xref ref-type="bibr" rid="pone.0007050-Mortusewicz1">&#x0005b;76&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Batta1">&#x0005b;77&#x0005d;</xref>. NonO (aka p54<sup>nrb</sup>) (<xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>), binds and helps SWI/SNF complexes activate transcription, and might be involved in splicing of the telomerase reverse transcriptase (<italic>TERT</italic>) gene <xref ref-type="bibr" rid="pone.0007050-Ito1">&#x0005b;78&#x0005d;</xref>. Requiem (single-peptide &#x0201c;hit&#x0201d;; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), validated in this study as BAF-associated <italic>in vivo</italic>, is a relatively uncharacterized transcription factor that regulates apoptosis in the myeloid lineage <xref ref-type="bibr" rid="pone.0007050-Gabig1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Wong1">&#x0005b;48&#x0005d;</xref>. LEDGF/p75 (single-peptide &#x0201c;hit&#x0201d;; <xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>) is a transcription factor that can bind human immunodeficiency virus type 1 (HIV-1) integrase directly, and contributes significantly to the efficiency and location of HIV-1 integration sites in human chromosomes <xref ref-type="bibr" rid="pone.0007050-Engelman1">&#x0005b;79&#x0005d;</xref>. BAF binds the HIV-1 matrix and Gag proteins directly, and is a component of HIV-1 virions <xref ref-type="bibr" rid="pone.0007050-Mansharamani1">&#x0005b;80&#x0005d;</xref>. BAF and emerin were both reported to contribute significantly to the efficiency of HIV-1 integration into primary human macrophages <xref ref-type="bibr" rid="pone.0007050-Jacque1">&#x0005b;33&#x0005d;</xref>. Two subsequent studies of emerin-null cells failed to support this role for emerin <xref ref-type="bibr" rid="pone.0007050-Shun1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Mulky1">&#x0005b;81&#x0005d;</xref>, and one study reported that siRNA-mediated downregulation of BAF had only modest effects on HIV-1 infectivity in HeLa-P4 cells <xref ref-type="bibr" rid="pone.0007050-Shun1">&#x0005b;34&#x0005d;</xref>. Further studies of macrophages and other primary cells are needed to test the proposed contribution of BAF to HIV-1 infection. Our results, which suggest a potential association between BAF and LEDGF, present a new way to study this question in HIV-1-infected primary cells.</p></sec><sec id="s3c"><title>BAF association with PARP1</title><p>BAF associated robustly <italic>in vivo</italic> with our best proteomic &#x0201c;hit&#x0201d;, PARP1. PARP1 transfers ADP-ribose units to itself and other proteins in an NAD<sup>&#x0002b;</sup>-dependent manner. PARP1 can promote higher-order compaction of nucleosome arrays and repress transcription <xref ref-type="bibr" rid="pone.0007050-Kim1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Wacker1">&#x0005b;82&#x0005d;</xref>, but can also activate transcription and has major roles in DNA repair <xref ref-type="bibr" rid="pone.0007050-Kim2">&#x0005b;83&#x0005d;</xref>. Our BAF proteome also included RecQ protein-like (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>), a DNA helicase involved in DNA repair that can associate with PARP1 <xref ref-type="bibr" rid="pone.0007050-Puranam1">&#x0005b;84&#x0005d;</xref>. PARP1 was shown previously to interact with A-type lamins <xref ref-type="bibr" rid="pone.0007050-Vidakovic1">&#x0005b;51&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Yusufzai1">&#x0005b;52&#x0005d;</xref>; our findings suggest these ternary complexes also include BAF, and a subset might also associate with emerin at the INM. How and when BAF associates with PARP1, and whether the BAF-PARP1 interaction includes RecQ, or requires lamins, are important new questions.</p></sec><sec id="s3d"><title>Implications of BAF association with RBBP4</title><p>Our independent validation suggests BAF associates preferentially with RBBP4, not RBBP7, under similar immunoprecipitation conditions. RBBP4 and RBBP7 are 89.4&#x00025; identical, and the majority of the amino acid changes are conservative substitutions (<xref ref-type="fig" rid="pone-0007050-g003">Figure 3C</xref>, grey boxes). Thus, BAF selectivity for RBBP4 over RBBP7 might be due to recognition of residues unique to RBBP4, or to an intermediary protein that discriminates RBBP4 from RBBP7. Understanding the basis for this preference might shed light on how DNA replication and DNA repair depend on the nuclear lamina network <xref ref-type="bibr" rid="pone.0007050-Manju1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Broers1">&#x0005b;85&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Shumaker3">&#x0005b;86&#x0005d;</xref>. RBBP4 is a chaperone common to H3.1, H3.3 and CenH3 deposition complexes, which assemble H3 into nucleosomes both during and independently of DNA replication <xref ref-type="bibr" rid="pone.0007050-Tagami1">&#x0005b;87&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-Furuyama1">&#x0005b;88&#x0005d;</xref>. BAF can bind H3.1 directly <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>, and has intriguing behavior in primary cells: BAF localizes to both the nucleus and cytoplasm of interphase cells except during S-phase, when it becomes exclusively nuclear <xref ref-type="bibr" rid="pone.0007050-Haraguchi3">&#x0005b;31&#x0005d;</xref>. S-phase is prolonged four hours in HeLa cells downregulated for BAF, suggesting BAF somehow facilitates S-phase progression <xref ref-type="bibr" rid="pone.0007050-Haraguchi3">&#x0005b;31&#x0005d;</xref>, through unknown mechanisms. RBBP4, as a component of the CAF-1 complex, associates indirectly with PCNA (a lamin A-binding protein <xref ref-type="bibr" rid="pone.0007050-Shumaker3">&#x0005b;86&#x0005d;</xref>) to promote chromatin assembly on newly-replicated or newly-repaired DNA <xref ref-type="bibr" rid="pone.0007050-Groth1">&#x0005b;89&#x0005d;</xref>. We propose BAF might dynamically stabilize chromatin complexes that include RBBP4 and PCNA by helping tether these complexes to lamins, analogous to the proposed BAF-mediated stabilization of emerin binding to lamin A <xref ref-type="bibr" rid="pone.0007050-Bengtsson1">&#x0005b;63&#x0005d;</xref>. Our proteome included another CAF-1 subunit, p60 (<xref ref-type="table" rid="pone-0007050-t001">Table 1</xref>); whether BAF associates with the CAF-1 complex itself remains to be tested. We also recovered both SPT16/p140 (<xref ref-type="table" rid="pone-0007050-t002">Table 2</xref>), the large subunit of the Facilitates Chromatin Transcription (FACT) chaperone complex, and its binding partner SSRP1/FACT p80 (<xref ref-type="table" rid="pone-0007050-t002">Table 2</xref>) which are involved in DNA replication, transcription and repair <xref ref-type="bibr" rid="pone.0007050-Reinberg1">&#x0005b;90&#x0005d;</xref>. RBBP4 (validated) and the FACT complex (not yet independently tested) each suggest mechanisms by which BAF might link chromatin assembly, replication, repair and other activities to the nuclear lamina network.</p></sec><sec id="s3e"><title>Proposed novel roles for BAF and emerin in DNA damage response</title><p>Human cells that transiently express certain laminopathy-causing lamin A mutations, show either reduced formation of &#x003b3;H2AX foci after DNA damage <xref ref-type="bibr" rid="pone.0007050-Manju1">&#x0005b;7&#x0005d;</xref> or higher proportions of &#x003b3;H2AX-positive cells in the absence of damage <xref ref-type="bibr" rid="pone.0007050-Scaffidi2">&#x0005b;91&#x0005d;</xref>. This suggests that DNA damage responses require an intact lamina network. Furthermore, nuclear alpha-II-spectrin, which binds and recruits specific repair proteins to sites of DNA damage <xref ref-type="bibr" rid="pone.0007050-Sridharan1">&#x0005b;92&#x0005d;</xref>, also co-precipitates with lamin A and emerin <xref ref-type="bibr" rid="pone.0007050-Sridharan2">&#x0005b;93&#x0005d;</xref> and co-purifies with emerin and lamin A in multi-protein complexes isolated from HeLa cells <xref ref-type="bibr" rid="pone.0007050-Holaska2">&#x0005b;94&#x0005d;</xref>. Our new results independently implicate both BAF and emerin in cellular responses to DNA damage. In undamaged HeLa cells, both proteins associated with CUL4A and DDB2; and FLAG-BAF also associated with endogenous DDB1 in HEK293&#x02236;BAF cells (unpublished observations), implying some kind of ongoing molecular surveillance or regulation that involves the nuclear envelope (emerin) and BAF. Our results suggest these interactions are regulated differentially after UV-induced damage and also potentially by apoptotic signaling, since the associations also increased at the time of PARP1 cleavage (120 min). We propose that BAF and emerin have dynamic and potentially regulated roles after DNA damage. Whether BAF and emerin function independently or concertedly, and whether their roles include the actual repair of damaged DNA, are open questions.</p><p>Our major conclusion is that this BAF proteome, validated for seven of 11 tested candidates, is a rich source of candidate proteins that might reveal how DNA damage responses, genome replication, epigenetic control and chromatin organization might be supported by BAF, and might be dynamically coupled to the nuclear envelope and nuclear lamina networks.</p></sec></sec><sec sec-type="materials|methods" id="s4"><title>Materials and methods</title><sec id="s4a"><title>Cell culture, nuclear protein lysates and affinity purification using BAF-beads</title><p>HeLa cells were obtained from the American Type Culture Collection and cultured in Dulbecco's modified eagle's medium containing 10&#x00025; fetal bovine serum. To prepare protein lysates, HeLa cells were resuspended in hypotonic buffer (10 mM HEPES pH 8, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5&#x00025; NP-40), incubated on ice 10 min and then lysed by 8&#x02013;10 passes through a 26G3/8 needle and syringe. Lysates were centrifuged (5000 rpm, 10 min, 4&#x000b0;C) to obtain the nuclear pellet, and nuclear proteins were solubilized by gentle rotation at 4&#x000b0;C in lysis buffer (20 mM HEPES pH 8, 150 mM NaCl, 0.1&#x00025; Triton X-100, 0.2 mM EDTA, 0.2 mM EGTA, 1.5 mM MgCl<sub>2</sub>, 2 mM DTT, benzonase to digest DNA, and protease inhibitors) for 30 min; samples were then centrifuged (5,000 rpm, 5 min, 4&#x000b0;C) to remove insoluble material, and solubilized nuclear lysate proteins were either used fresh or stored at &#x02212;80&#x000b0;C after being flash frozen with liquid nitrogen.</p><p>BAF-conjugated beads were made by incubating 30 &#x000b5;g purified isolated H<sub>6</sub>BAF dimers prepared by affinity purification and size exclusion chromatography as described <xref ref-type="bibr" rid="pone.0007050-Zheng1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007050-MontesdeOca1">&#x0005b;28&#x0005d;</xref>, with 30 &#x000b5;l Ni-NTA beads (Qiagen, Valencia, CA) overnight at 4&#x000b0;C, at a final protein concentration of 1 &#x000b5;g/&#x003bc;l. Control beads were incubated with lysis buffer only. Ni-alone or Ni-BAF beads were then each washed twice with lysis buffer and incubated with 500 &#x000b5;g pre-cleared nuclear lysate proteins, rotating, for 3 hrs at 4&#x000b0;C. Unbound material was removed by four washes with lysis buffer lacking detergent. Bound proteins were eluted sequentially, first with lysis buffer containing 0.3 M NaCl (no detergent), then with lysis buffer containing 1 M NaCl (no detergent), both compatible with in-solution trypsin digestion for LC-MS/MS, and finally with 0.5&#x00025; SDS. The remaining beads were resuspended in 2X-SDS sample buffer (2X-SB). About 10&#x00025; of each eluate was resolved by SDS-PAGE and silver stained for qualitative analysis. Two pairs of samples were analyzed in solution by LC-MS/MS: Ni-alone (0.3 M and 1 M NaCl eluates) and Ni-BAF (0.3 M and 1 M NaCl eluates). For samples analyzed by iTRAQ (below), we used 100 &#x000b5;g Ni-BAF beads (final BAF concentration 1 &#x000b5;g/&#x003bc;l) and 5 mg nuclear lysate proteins.</p></sec><sec id="s4b"><title>Liquid Chromatography-Coupled Tandem Mass Spectrometry</title><p>Eluted proteins were reduced and alkylated in solution using iodoacetamide, and proteolyzed with sequencing grade modified porcine trypsin (Promega, Madison, WI) as described <xref ref-type="bibr" rid="pone.0007050-Shevchenko1">&#x0005b;95&#x0005d;</xref>. Protein identification by LC-MS/MS analysis of peptides was performed with an LTQ ion trap MS (Thermo Fisher Scientific, San Jose, CA) interfaced with a 2D nanoLC system (Eksigent, Dublin, CA). Peptides were fractionated by reverse-phase HPLC on a 75 &#x000b5;m&#x000d7;100 mm C18 column with a 10 &#x000b5;m emitter using a 0&#x02013;60&#x00025; acetonitrile/0.5&#x00025; formic acid gradient over 30 min at 300 nl/min. Peptide sequences were identified using Mascot software (version 2.2, Matrix Science, Boston, MA) to search the NCBI non-redundant database with the acquired fragmentation data. Identified sequences were confirmed manually by inspecting the fragmentation spectra. Scaffold (version Scaffold_2_04_00, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 0&#x00025; probability as specified by the Peptide Prophet algorithm <xref ref-type="bibr" rid="pone.0007050-Keller1">&#x0005b;96&#x0005d;</xref> embedded within Scaffold. Low probability enabled potentially significant protein identifications based on many moderate-probability peptides, but no such proteins emerged; instead nearly all identifications were based on peptides with individual confidences &#x0003e;80&#x00025; (<xref ref-type="supplementary-material" rid="pone.0007050.s001">Table S1</xref>). Protein identifications were accepted if they could be established at greater than 89&#x00025; probability based on at least 1 identified peptide. Two &#x0201c;single-hit&#x0201d; candidates were subsequently validated as BAF-associated <italic>in vivo</italic>, as described in <xref ref-type="sec" rid="s2">Results</xref>. Protein probabilities were assigned by the embedded Protein Prophet algorithm <xref ref-type="bibr" rid="pone.0007050-Nesvizhskii1">&#x0005b;97&#x0005d;</xref>. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.</p></sec><sec id="s4c"><title>Isobaric Tagging for Relative and Absolute Quantitation</title><p>All four eluates (&#x0223c;10 &#x000b5;g protein, each) were dissolved in 20 &#x000b5;l 0.1&#x00025; SDS in 0.5 M triethylammonium bicarbonate, reduced, alkylated and digested at 37&#x000b0;C overnight with trypsin at a protein-to-enzyme ratio of 20&#x02236;1. The iTRAQ reagents (4-plex, Applied Biosystems - MDX Sciex, Foster City, CA) were dissolved in 70 &#x000b5;l ethanol, added to each digest, and incubated 1 hr at 22&#x02013;25&#x000b0;C. The four samples, designated Ni-control-0.3 M eluate, BAF-0.3 M eluate, Ni-control-1 M eluate and BAF-1 M eluate, were labeled with iTRAQ reagents 114, 115, 116 and 117, respectively. After labeling, all samples were mixed and dried down to a volume of 50 &#x000b5;l. The combined peptide mixture was fractionated by Strong Cation Exchange chromatography (SCX) on a 1100 HPLC system (Agilent, Santa Clara, CA) using a PolySulfoethyl A column (2.1&#x000d7;100 mm, 5 &#x000b5;m, 300 &#x000c5;, PolyLC, Columbia, MD), by first dissolving the sample in 4 mls SCX loading buffer (25&#x00025; v/v acetonitrile, 10 mM KH<sub>2</sub>PO<sub>4</sub> pH 2.8, adjusted with 1 N phosphoric acid), then loading the sample onto the column and washing isocratically for 30 min at 250 &#x000b5;l/min. Peptides were eluted by a gradient of 0&#x02013;350 mM KCl (25&#x00025; v/v acetonitrile, 10 mM KH<sub>2</sub>PO<sub>4</sub> pH 2.8) over 40 min at a flow rate of 250 &#x000b5;l/min. The 214 nm absorbance was monitored and 10-SCX fractions were collected along the gradient. Each SCX fraction was dried down, dissolved in 40 &#x000b5;l 0.1&#x00025; formic acid, and analyzed on a QSTAR Pulsar&#x02122; (Applied Biosystems - MDS Sciex, Foster City, CA) interfaced with an Eksigent nano-LC system (Dublin, CA). Peptides were separated on a reverse-phase column packed with 10 cm of C18 beads (360&#x000d7;75 &#x000b5;m, 5 &#x000b5;m, 120 &#x000c5;, YMC ODS-AQ; Waters Milford, MA) with a 10 &#x000b5;m emitter tip (New Objective, Woburn, MA) attached. Peptides eluting from an HPLC gradient of 5&#x02013;36&#x00025; acetonitrile in 0.1&#x00025; formic acid, over 60 min at a 300 nl/min flow rate, were sprayed into the QSTAR. Survey scans were acquired from <italic>m/z</italic> 350&#x02013;1200 with up to three precursors selected for MS/MS using a dynamic exclusion of 45 sec. A rolling collision energy was used to promote fragmentation and the collision energy range was &#x0223c;20&#x00025; higher than that used for unlabeled peptides due to iTRAQ tags.</p><p>MS/MS spectra were extracted and searched against the SwissProt database using ProteinPilot&#x02122; software (Applied Biosystems, Foster City, CA) with Paragon&#x02122; method and the following parameters: all species, trypsin as enzyme (one missed cleavage allowed), cysteine static modification with methylmethanethiosulfate and iTRAQ (peptide labeled at N-terminal and lysine) as sample type. Mass tolerance was set to 0.2 Da for precursor and 0.15 Da for fragment ions. The raw peptide identification results from Paragon&#x02122; Algorithm (Applied Biosystems, Foster City, CA) searches were further processed by the Pro Group&#x02122; Algorithm (Applied Biosystems, Foster City, CA) within the ProteinPilot&#x02122; software before they were displayed. The Pro Group&#x02122; Algorithm uses the peptide identification results to determine the minimal set of proteins that can be reported for a given protein confidence threshold. The peptide confidence threshold cutoff for the iTRAQ study was at least 95&#x00025; (see <xref ref-type="table" rid="pone-0007050-t003">Table 3</xref>).</p></sec><sec id="s4d"><title>Protein expression plasmids, transfections and immunoprecipitations</title><p>FLAG-tagged constructs for the following proteins were used: MTA2 and Mi2&#x003b2; (<xref ref-type="bibr" rid="pone.0007050-Zhang2">&#x0005b;41&#x0005d;</xref>; provided by Y. Zhang, Univ. North Carolina, Chapel Hill), DPY-30-like (<xref ref-type="bibr" rid="pone.0007050-Cho1">&#x0005b;42&#x0005d;</xref>; provided by K. Ge, NIH), Requiem (provided by E. M. Chan, Eli Lilly Corp.), human PARP1 (<xref ref-type="bibr" rid="pone.0007050-Kim1">&#x0005b;37&#x0005d;</xref>; provided by W.L. Kraus, Cornell Univ.), CUL4A and DDB2 (provided by H. Wang, Univ. Alabama, Birmingham), GFP-tagged RBBP4 and RBBP7 (provided by T. Misteli, NIH). Each construct and its corresponding empty FLAG or GFP vector were transiently transfected into HeLa cells using LT1 (Mirus, Madison, WI) per manufacturer instructions and expressed for 24 hrs. Cells were then lysed by incubating 10 min on ice in immunoprecipitation (IP) buffer (20 mM HEPES pH 8, 300 mM NaCl, 0.3&#x00025; Triton X-100, 0.2 mM EDTA, 0.2 mM EGTA, 1.5 mM MgCl<sub>2</sub>, 2 mM DTT, protease inhibitors, and benzonase &#x0005b;300 U/&#x003bc;l; EMD Chemicals Inc., Gibbstown, NJ&#x0005d;). Lysates were then diluted 1&#x02236;1 v/v with IP buffer to achieve final concentrations of 150 mM NaCl and 0.15&#x00025; TX-100, incubated 10 more min on ice, sonicated 4 times (15 sec each) and centrifuged (50,000 rpm, 30 min, 4&#x000b0;C) to recover soluble proteins for subsequent immunoprecipitation. For Flag immunoprecipitations, 250 &#x000b5;l lysate was incubated 4 hrs (4&#x000b0;C) with 3 &#x000b5;l Flag-M2 agarose beads (Sigma, St. Louis, MO), then pelleted and washed 4 times with IP buffer. Bound proteins were eluted using either 2X-SB, or by two successive incubations (37&#x000b0;C, 10 min, each) with 100 &#x000b5;g/ml Flag-peptide (Sigma F4799; St. Louis, MO) when indicated. For GFP immunoprecipitations 250 &#x000b5;l lysate were incubated for 1 hr with 1 &#x000b5;l GFP antibody (Molecular Probes, A6455; Carlsbad, CA), after which 10 &#x000b5;l GammaBind G sepharose beads (Amersham, Piscataway, NJ) were added and incubation proceeded for 4 hrs more at 4&#x000b0;C. Beads were then pelleted and washed as above, and proteins were eluted with 2X-SB, resolved by SDS-PAGE (4&#x02013;12&#x00025; NuPAGE&#x02122; gels; Invitrogen Carlsbad, CA) and Western blotted with the following antibodies: rabbit anti-Flag (1&#x02236;7000 dilution; Sigma F7425; St. Louis, MO), mouse anti-GFP (1&#x02236;5,000; Santa Cruz Biotechnologies, sc-9996; Santa Cruz, CA), rabbit anti-Emerin (1&#x02236;2,000; Santa Cruz Biotechnologies, sc-15378; Santa Cruz, CA), rabbit anti-Lamin A/C (1&#x02236;2,000; Santa Cruz Biotechnologies, sc-20681; Santa Cruz, CA), rabbit anti-DDB1 (1&#x02236;1,000; Abcam 21080; Cambridge, MA), mouse anti-PARP1 (1&#x02236;5,000; BD Pharmingen 556362; San Jose, CA), mouse anti-&#x003b3;-tubulin (1&#x02236;500,000; Sigma T6557; St. Louis, MO) and rabbit serum 3273 against BAF (1&#x02236;10,000 dilution; <xref ref-type="bibr" rid="pone.0007050-Haraguchi1">&#x0005b;15&#x0005d;</xref>). Western blots were visualized by horseradish peroxidase chemiluminescence (Amersham, Piscataway, NJ).</p></sec><sec id="s4e"><title>UV irradiation of transiently transfected HeLa cells</title><p>About 22&#x02013;24 hrs after transfection cells were UV-irradiated (20 J/m<sup>2</sup>) using a Stratagene UV Stratalinker 2400 (Stratagene, La Jolla, CA), given fresh media and allowed to recover for the indicated time, then harvested with a rubber policeman, washed once with ice-cold PBS, pelleted (1,500 rpm, 5 min, 4&#x000b0;C) and processed for immunoprecipitation as described above.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0007050.s001"><label>Table S1</label><caption><p>Excel spreadsheet showing peptides used to identify proteins with at least 89&#x00025; confidence, as determined by Scaffold analysis of LC-MS/MS results for each eluate (0.3 M no BAF, 0.3 M BAF, 1 M no BAF, 1 M BAF).</p><p>(1.53 MB XLS)</p></caption><media xlink:href="pone.0007050.s001.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are grateful to Y. Zhang (UNC Chapel Hill), K. Ge (NIH), E.M Chan (Eli Lilly Corp.), W.L. Kraus (Cornell), H. Wang (UA Birmingham) and T. Misteli (NIH) for constructs and reagents used in this work, and the Wilson lab for ongoing discussions and comments.</p></ack><ref-list><title>References</title><ref id="pone.0007050-Shaklai1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaklai</surname><given-names>S</given-names></name><name><surname>Amariglio</surname><given-names>N</given-names></name><name><surname>Rechavi</surname><given-names>G</given-names></name><name><surname>Simon</surname><given-names>AJ</given-names></name></person-group><year>2007</year><article-title>Gene silencing at the nuclear periphery.</article-title><source>FEBS J</source><volume>274</volume><fpage>1383</fpage><lpage>1392</lpage><pub-id pub-id-type="pmid">17489096</pub-id></mixed-citation></ref><ref id="pone.0007050-Guelen1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guelen</surname><given-names>L</given-names></name><name><surname>Pagie</surname><given-names>L</given-names></name><name><surname>Brasset</surname><given-names>E</given-names></name><name><surname>Meuleman</surname><given-names>W</given-names></name><name><surname>Faza</surname><given-names>MB</given-names></name><etal/></person-group><year>2008</year><article-title>Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions.</article-title><source>Nature</source><volume>453</volume><fpage>948</fpage><lpage>951</lpage><pub-id pub-id-type="pmid">18463634</pub-id></mixed-citation></ref><ref id="pone.0007050-Bridger1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridger</surname><given-names>JM</given-names></name><name><surname>Foeger</surname><given-names>N</given-names></name><name><surname>Kill</surname><given-names>IR</given-names></name><name><surname>Herrmann</surname><given-names>H</given-names></name></person-group><year>2007</year><article-title>The nuclear lamina. Both a structural framework and a platform for genome organization.</article-title><source>FEBS J</source><volume>274</volume><fpage>1354</fpage><lpage>1361</lpage><pub-id pub-id-type="pmid">17489093</pub-id></mixed-citation></ref><ref id="pone.0007050-Dorner1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname><given-names>D</given-names></name><name><surname>Gotzmann</surname><given-names>J</given-names></name><name><surname>Foisner</surname><given-names>R</given-names></name></person-group><year>2007</year><article-title>Nucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation.</article-title><source>FEBS J</source><volume>274</volume><fpage>1362</fpage><lpage>1373</lpage><pub-id pub-id-type="pmid">17489094</pub-id></mixed-citation></ref><ref id="pone.0007050-Shumaker1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Dechat</surname><given-names>T</given-names></name><name><surname>Kohlmaier</surname><given-names>A</given-names></name><name><surname>Adam</surname><given-names>SA</given-names></name><name><surname>Bozovsky</surname><given-names>MR</given-names></name><etal/></person-group><year>2006</year><article-title>Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>8703</fpage><lpage>8708</lpage><pub-id pub-id-type="pmid">16738054</pub-id></mixed-citation></ref><ref id="pone.0007050-Capell1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capell</surname><given-names>BC</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name></person-group><year>2006</year><article-title>Human laminopathies: nuclei gone genetically awry.</article-title><source>Nat Rev Genet</source><volume>7</volume><fpage>940</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">17139325</pub-id></mixed-citation></ref><ref id="pone.0007050-Manju1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manju</surname><given-names>K</given-names></name><name><surname>Muralikrishna</surname><given-names>B</given-names></name><name><surname>Parnaik</surname><given-names>VK</given-names></name></person-group><year>2006</year><article-title>Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci.</article-title><source>J Cell Sci</source><volume>119</volume><fpage>2704</fpage><lpage>2714</lpage><pub-id pub-id-type="pmid">16772334</pub-id></mixed-citation></ref><ref id="pone.0007050-Ramirez1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>CL</given-names></name><name><surname>Cadinanos</surname><given-names>J</given-names></name><name><surname>Varela</surname><given-names>I</given-names></name><name><surname>Freije</surname><given-names>JM</given-names></name><name><surname>Lopez-Otin</surname><given-names>C</given-names></name></person-group><year>2007</year><article-title>Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions.</article-title><source>Cell Mol Life Sci</source><volume>64</volume><fpage>155</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">17131053</pub-id></mixed-citation></ref><ref id="pone.0007050-Jacob1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>KN</given-names></name><name><surname>Garg</surname><given-names>A</given-names></name></person-group><year>2006</year><article-title>Laminopathies: multisystem dystrophy syndromes.</article-title><source>Mol Genet Metab</source><volume>87</volume><fpage>289</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16364671</pub-id></mixed-citation></ref><ref id="pone.0007050-Worman1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worman</surname><given-names>HJ</given-names></name><name><surname>Bonne</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>&#x0201c;Laminopathies&#x0201d;: a wide spectrum of human diseases.</article-title><source>Exp Cell Res</source><volume>313</volume><fpage>2121</fpage><lpage>2133</lpage><pub-id pub-id-type="pmid">17467691</pub-id></mixed-citation></ref><ref id="pone.0007050-Scaffidi1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaffidi</surname><given-names>P</given-names></name><name><surname>Misteli</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.</article-title><source>Nat Med</source><volume>11</volume><fpage>440</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">15750600</pub-id></mixed-citation></ref><ref id="pone.0007050-Holaska1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holaska</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Kowalski</surname><given-names>AK</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2003</year><article-title>Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>6969</fpage><lpage>6975</lpage><pub-id pub-id-type="pmid">12493765</pub-id></mixed-citation></ref><ref id="pone.0007050-Margalit1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margalit</surname><given-names>A</given-names></name><name><surname>Brachner</surname><given-names>A</given-names></name><name><surname>Gotzmann</surname><given-names>J</given-names></name><name><surname>Foisner</surname><given-names>R</given-names></name><name><surname>Gruenbaum</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>Barrier-to-autointegration factor&#x02013;a BAFfling little protein.</article-title><source>Trends Cell Biol</source><volume>17</volume><fpage>202</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">17320395</pub-id></mixed-citation></ref><ref id="pone.0007050-Wagner1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>N</given-names></name><name><surname>Krohne</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>LEM-Domain proteins: new insights into lamin-interacting proteins.</article-title><source>Int Rev Cytol</source><volume>261</volume><fpage>1</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">17560279</pub-id></mixed-citation></ref><ref id="pone.0007050-Haraguchi1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname><given-names>T</given-names></name><name><surname>Koujin</surname><given-names>T</given-names></name><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Matsuoka</surname><given-names>Y</given-names></name><etal/></person-group><year>2001</year><article-title>BAF is required for emerin assembly into the reforming nuclear envelope.</article-title><source>J Cell Sci</source><volume>114</volume><fpage>4575</fpage><lpage>4585</lpage><pub-id pub-id-type="pmid">11792822</pub-id></mixed-citation></ref><ref id="pone.0007050-Liu1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Neufeld</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name><etal/></person-group><year>2003</year><article-title>MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>4598</fpage><lpage>4603</lpage><pub-id pub-id-type="pmid">12684533</pub-id></mixed-citation></ref><ref id="pone.0007050-Margalit2"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margalit</surname><given-names>A</given-names></name><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Gruenbaum</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2005</year><article-title>Barrier-to-autointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>3290</fpage><lpage>3295</lpage><pub-id pub-id-type="pmid">15728376</pub-id></mixed-citation></ref><ref id="pone.0007050-Haraguchi2"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname><given-names>T</given-names></name><name><surname>Kojidani</surname><given-names>T</given-names></name><name><surname>Koujin</surname><given-names>T</given-names></name><name><surname>Shimi</surname><given-names>T</given-names></name><name><surname>Osakada</surname><given-names>H</given-names></name><etal/></person-group><year>2008</year><article-title>Live cell imaging and electron microscopy reveal dynamic processes of BAF-directed nuclear envelope assembly.</article-title><source>J Cell Sci</source><volume>121</volume><fpage>2540</fpage><lpage>2554</lpage><pub-id pub-id-type="pmid">18628300</pub-id></mixed-citation></ref><ref id="pone.0007050-SeguraTotten1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2004</year><article-title>BAF: roles in chromatin, nuclear structure and retrovirus integration.</article-title><source>Trends Cell Biol</source><volume>14</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">15130582</pub-id></mixed-citation></ref><ref id="pone.0007050-Lee1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name></person-group><year>1998</year><article-title>A previously unidentified host protein protects retroviral DNA from autointegration.</article-title><source>Proc Natl Acad Sci U S A</source><volume>95</volume><fpage>1528</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">9465049</pub-id></mixed-citation></ref><ref id="pone.0007050-Cai1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>SQ</given-names></name><name><surname>Ghirlando</surname><given-names>R</given-names></name><etal/></person-group><year>1998</year><article-title>Solution structure of the cellular factor BAF responsible for protecting retroviral DNA from autointegration.</article-title><source>Nat Struct Biol</source><volume>5</volume><fpage>903</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">9783751</pub-id></mixed-citation></ref><ref id="pone.0007050-Harris1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>D</given-names></name><name><surname>Engelman</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>39671</fpage><lpage>39677</lpage><pub-id pub-id-type="pmid">11005805</pub-id></mixed-citation></ref><ref id="pone.0007050-Zheng1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Ghirlando</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Mizuuchi</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>8997</fpage><lpage>9002</lpage><pub-id pub-id-type="pmid">10908652</pub-id></mixed-citation></ref><ref id="pone.0007050-Bradley1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>CM</given-names></name><name><surname>Ronning</surname><given-names>DR</given-names></name><name><surname>Ghirlando</surname><given-names>R</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name><name><surname>Dyda</surname><given-names>F</given-names></name></person-group><year>2005</year><article-title>Structural basis for DNA bridging by barrier-to-autointegration factor.</article-title><source>Nat Struct Mol Biol</source><volume>12</volume><fpage>935</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">16155580</pub-id></mixed-citation></ref><ref id="pone.0007050-Shimi1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimi</surname><given-names>T</given-names></name><name><surname>Koujin</surname><given-names>T</given-names></name><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name><name><surname>Haraguchi</surname><given-names>T</given-names></name><etal/></person-group><year>2004</year><article-title>Dynamic interaction between BAF and emerin revealed by FRAP, FLIP, and FRET analyses in living HeLa cells.</article-title><source>J Struct Biol</source><volume>147</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">15109603</pub-id></mixed-citation></ref><ref id="pone.0007050-Margalit3"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margalit</surname><given-names>A</given-names></name><name><surname>Neufeld</surname><given-names>E</given-names></name><name><surname>Feinstein</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name><name><surname>Podbilewicz</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Barrier to autointegration factor blocks premature cell fusion and maintains adult muscle integrity in C. elegans.</article-title><source>J Cell Biol</source><volume>178</volume><fpage>661</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">17698609</pub-id></mixed-citation></ref><ref id="pone.0007050-Dechat1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dechat</surname><given-names>T</given-names></name><name><surname>Gajewski</surname><given-names>A</given-names></name><name><surname>Korbei</surname><given-names>B</given-names></name><name><surname>Gerlich</surname><given-names>D</given-names></name><name><surname>Daigle</surname><given-names>N</given-names></name><etal/></person-group><year>2004</year><article-title>LAP2alpha and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assembly.</article-title><source>J Cell Sci</source><volume>117</volume><fpage>6117</fpage><lpage>6128</lpage><pub-id pub-id-type="pmid">15546916</pub-id></mixed-citation></ref><ref id="pone.0007050-MontesdeOca1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montes de Oca</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2005</year><article-title>Binding of barrier to autointegration factor (BAF) to histone H3 and selected linker histones including H1.1.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>42252</fpage><lpage>42262</lpage><pub-id pub-id-type="pmid">16203725</pub-id></mixed-citation></ref><ref id="pone.0007050-SeguraTotten2"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura-Totten</surname><given-names>M</given-names></name><name><surname>Kowalski</surname><given-names>AK</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2002</year><article-title>Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly.</article-title><source>J Cell Biol</source><volume>158</volume><fpage>475</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">12163470</pub-id></mixed-citation></ref><ref id="pone.0007050-Furukawa1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Sugiyama</surname><given-names>S</given-names></name><name><surname>Osouda</surname><given-names>S</given-names></name><name><surname>Goto</surname><given-names>H</given-names></name><name><surname>Inagaki</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>Barrier-to-autointegration factor plays crucial roles in cell cycle progression and nuclear organization in Drosophila.</article-title><source>J Cell Sci</source><volume>116</volume><fpage>3811</fpage><lpage>3823</lpage><pub-id pub-id-type="pmid">12902403</pub-id></mixed-citation></ref><ref id="pone.0007050-Haraguchi3"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname><given-names>T</given-names></name><name><surname>Koujin</surname><given-names>T</given-names></name><name><surname>Osakada</surname><given-names>H</given-names></name><name><surname>Kojidani</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cells.</article-title><source>J Cell Sci</source><volume>120</volume><fpage>1967</fpage><lpage>1977</lpage><pub-id pub-id-type="pmid">17519288</pub-id></mixed-citation></ref><ref id="pone.0007050-Wang1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Rivolta</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>LY</given-names></name><name><surname>Peng</surname><given-names>GH</given-names></name><etal/></person-group><year>2002</year><article-title>Barrier to autointegration factor interacts with the cone-rod homeobox and represses its transactivation function.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>43288</fpage><lpage>43300</lpage><pub-id pub-id-type="pmid">12215455</pub-id></mixed-citation></ref><ref id="pone.0007050-Jacque1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacque</surname><given-names>JM</given-names></name><name><surname>Stevenson</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity.</article-title><source>Nature</source><volume>441</volume><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">16680152</pub-id></mixed-citation></ref><ref id="pone.0007050-Shun1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shun</surname><given-names>MC</given-names></name><name><surname>Daigle</surname><given-names>JE</given-names></name><name><surname>Vandegraaff</surname><given-names>N</given-names></name><name><surname>Engelman</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein.</article-title><source>J Virol</source><volume>81</volume><fpage>166</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">17035312</pub-id></mixed-citation></ref><ref id="pone.0007050-Ross1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>YN</given-names></name><name><surname>Marchese</surname><given-names>JN</given-names></name><name><surname>Williamson</surname><given-names>B</given-names></name><name><surname>Parker</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.</article-title><source>Mol Cell Proteomics</source><volume>3</volume><fpage>1154</fpage><lpage>1169</lpage><pub-id pub-id-type="pmid">15385600</pub-id></mixed-citation></ref><ref id="pone.0007050-Goldberg1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>M</given-names></name><name><surname>Harel</surname><given-names>A</given-names></name><name><surname>Brandeis</surname><given-names>M</given-names></name><name><surname>Rechsteiner</surname><given-names>T</given-names></name><name><surname>Richmond</surname><given-names>TJ</given-names></name><etal/></person-group><year>1999</year><article-title>The tail domain of lamin Dm0 binds histones H2A and H2B.</article-title><source>Proc Natl Acad Sci USA</source><volume>96</volume><fpage>2852</fpage><lpage>2857</lpage><pub-id pub-id-type="pmid">10077600</pub-id></mixed-citation></ref><ref id="pone.0007050-Kim1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Mauro</surname><given-names>S</given-names></name><name><surname>Gevry</surname><given-names>N</given-names></name><name><surname>Lis</surname><given-names>JT</given-names></name><name><surname>Kraus</surname><given-names>WL</given-names></name></person-group><year>2004</year><article-title>NAD&#x0002b;-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.</article-title><source>Cell</source><volume>119</volume><fpage>803</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">15607977</pub-id></mixed-citation></ref><ref id="pone.0007050-Costanzi1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costanzi</surname><given-names>C</given-names></name><name><surname>Pehrson</surname><given-names>JR</given-names></name></person-group><year>1998</year><article-title>Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals.</article-title><source>Nature</source><volume>393</volume><fpage>599</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">9634239</pub-id></mixed-citation></ref><ref id="pone.0007050-Goldberg2"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>M</given-names></name><name><surname>Stucki</surname><given-names>M</given-names></name><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>D'Amours</surname><given-names>D</given-names></name><name><surname>Rahman</surname><given-names>D</given-names></name><etal/></person-group><year>2003</year><article-title>MDC1 is required for the intra-S-phase DNA damage checkpoint.</article-title><source>Nature</source><volume>421</volume><fpage>952</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">12607003</pub-id></mixed-citation></ref><ref id="pone.0007050-Zhang1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>LeRoy</surname><given-names>G</given-names></name><name><surname>Seelig</surname><given-names>HP</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><year>1998</year><article-title>The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.</article-title><source>Cell</source><volume>95</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">9790534</pub-id></mixed-citation></ref><ref id="pone.0007050-Zhang2"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Bird</surname><given-names>A</given-names></name><etal/></person-group><year>1999</year><article-title>Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.</article-title><source>Genes Dev</source><volume>13</volume><fpage>1924</fpage><lpage>1935</lpage><pub-id pub-id-type="pmid">10444591</pub-id></mixed-citation></ref><ref id="pone.0007050-Cho1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YW</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>20395</fpage><lpage>20406</lpage><pub-id pub-id-type="pmid">17500065</pub-id></mixed-citation></ref><ref id="pone.0007050-Tachibana1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name></person-group><year>2001</year><article-title>Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>25309</fpage><lpage>25317</lpage><pub-id pub-id-type="pmid">11316813</pub-id></mixed-citation></ref><ref id="pone.0007050-Collins1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>RE</given-names></name><name><surname>Northrop</surname><given-names>JP</given-names></name><name><surname>Horton</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>DY</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><year>2008</year><article-title>The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules.</article-title><source>Nat Struct Mol Biol</source><volume>15</volume><fpage>245</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">18264113</pub-id></mixed-citation></ref><ref id="pone.0007050-Bannister1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Zegerman</surname><given-names>P</given-names></name><name><surname>Partridge</surname><given-names>JF</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name><name><surname>Thomas</surname><given-names>JO</given-names></name><etal/></person-group><year>2001</year><article-title>Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.</article-title><source>Nature</source><volume>410</volume><fpage>120</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">11242054</pub-id></mixed-citation></ref><ref id="pone.0007050-Jacobs1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>SA</given-names></name><name><surname>Taverna</surname><given-names>SD</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Briggs</surname><given-names>SD</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><year>2001</year><article-title>Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3.</article-title><source>EMBO J</source><volume>20</volume><fpage>5232</fpage><lpage>5241</lpage><pub-id pub-id-type="pmid">11566886</pub-id></mixed-citation></ref><ref id="pone.0007050-Gabig1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabig</surname><given-names>TG</given-names></name><name><surname>Mantel</surname><given-names>PL</given-names></name><name><surname>Rosli</surname><given-names>R</given-names></name><name><surname>Crean</surname><given-names>CD</given-names></name></person-group><year>1994</year><article-title>Requiem: a novel zinc finger gene essential for apoptosis in myeloid cells.</article-title><source>J Biol Chem</source><volume>269</volume><fpage>29515</fpage><lpage>29519</lpage><pub-id pub-id-type="pmid">7961935</pub-id></mixed-citation></ref><ref id="pone.0007050-Wong1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DC</given-names></name><name><surname>Wong</surname><given-names>KT</given-names></name><name><surname>Nissom</surname><given-names>PM</given-names></name><name><surname>Heng</surname><given-names>CK</given-names></name><name><surname>Yap</surname><given-names>MG</given-names></name></person-group><year>2006</year><article-title>Targeting early apoptotic genes in batch and fed-batch CHO cell cultures.</article-title><source>Biotechnol Bioeng</source><volume>95</volume><fpage>350</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">16894638</pub-id></mixed-citation></ref><ref id="pone.0007050-DAmours1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amours</surname><given-names>D</given-names></name><name><surname>Desnoyers</surname><given-names>S</given-names></name><name><surname>D'Silva</surname><given-names>I</given-names></name><name><surname>Poirier</surname><given-names>GG</given-names></name></person-group><year>1999</year><article-title>Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.</article-title><source>Biochem J</source><volume>342(Pt 2)</volume><fpage>249</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">10455009</pub-id></mixed-citation></ref><ref id="pone.0007050-Wiebe1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiebe</surname><given-names>MS</given-names></name><name><surname>Traktman</surname><given-names>P</given-names></name></person-group><year>2007</year><article-title>Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication.</article-title><source>Cell Host Microbe</source><volume>1</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">18005698</pub-id></mixed-citation></ref><ref id="pone.0007050-Vidakovic1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidakovic</surname><given-names>M</given-names></name><name><surname>Grdovic</surname><given-names>N</given-names></name><name><surname>Quesada</surname><given-names>P</given-names></name><name><surname>Bode</surname><given-names>J</given-names></name><name><surname>Poznanovic</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>Poly(ADP-ribose) polymerase-1: association with nuclear lamins in rodent liver cells.</article-title><source>J Cell Biochem</source><volume>93</volume><fpage>1155</fpage><lpage>1168</lpage><pub-id pub-id-type="pmid">15486973</pub-id></mixed-citation></ref><ref id="pone.0007050-Yusufzai1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusufzai</surname><given-names>TM</given-names></name><name><surname>Tagami</surname><given-names>H</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Felsenfeld</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species.</article-title><source>Mol Cell</source><volume>13</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">14759373</pub-id></mixed-citation></ref><ref id="pone.0007050-Ridgway1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridgway</surname><given-names>P</given-names></name><name><surname>Almouzni</surname><given-names>G</given-names></name></person-group><year>2000</year><article-title>CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair.</article-title><source>J Cell Sci</source><volume>113(Pt 15)</volume><fpage>2647</fpage><lpage>2658</lpage><pub-id pub-id-type="pmid">10893180</pub-id></mixed-citation></ref><ref id="pone.0007050-Polo1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polo</surname><given-names>SE</given-names></name><name><surname>Roche</surname><given-names>D</given-names></name><name><surname>Almouzni</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>New histone incorporation marks sites of UV repair in human cells.</article-title><source>Cell</source><volume>127</volume><fpage>481</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">17081972</pub-id></mixed-citation></ref><ref id="pone.0007050-Qian1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>YW</given-names></name><name><surname>Lee</surname><given-names>EY</given-names></name></person-group><year>1995</year><article-title>Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast.</article-title><source>J Biol Chem</source><volume>270</volume><fpage>25507</fpage><lpage>25513</lpage><pub-id pub-id-type="pmid">7503932</pub-id></mixed-citation></ref><ref id="pone.0007050-Fujiwara1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Masutani</surname><given-names>C</given-names></name><name><surname>Mizukoshi</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>J</given-names></name><name><surname>Hanaoka</surname><given-names>F</given-names></name><etal/></person-group><year>1999</year><article-title>Characterization of DNA recognition by the human UV-damaged DNA-binding protein.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>20027</fpage><lpage>20033</lpage><pub-id pub-id-type="pmid">10391953</pub-id></mixed-citation></ref><ref id="pone.0007050-Moser1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>J</given-names></name><name><surname>Volker</surname><given-names>M</given-names></name><name><surname>Kool</surname><given-names>H</given-names></name><name><surname>Alekseev</surname><given-names>S</given-names></name><name><surname>Vrieling</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.</article-title><source>DNA Repair (Amst)</source><volume>4</volume><fpage>571</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">15811629</pub-id></mixed-citation></ref><ref id="pone.0007050-Wang2"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhai</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Joo</surname><given-names>HY</given-names></name><name><surname>Jackson</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage.</article-title><source>Mol Cell</source><volume>22</volume><fpage>383</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">16678110</pub-id></mixed-citation></ref><ref id="pone.0007050-Dai1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><year>2006</year><article-title>&#x0201c;Cullin 4 makes its mark on chromatin&#x0201d;.</article-title><source>Cell Div</source><volume>1</volume><fpage>14</fpage><pub-id pub-id-type="pmid">16831222</pub-id></mixed-citation></ref><ref id="pone.0007050-DAmours2"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amours</surname><given-names>D</given-names></name><name><surname>Sallmann</surname><given-names>FR</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name><name><surname>Poirier</surname><given-names>GG</given-names></name></person-group><year>2001</year><article-title>Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis.</article-title><source>J Cell Sci</source><volume>114</volume><fpage>3771</fpage><lpage>3778</lpage><pub-id pub-id-type="pmid">11707529</pub-id></mixed-citation></ref><ref id="pone.0007050-Li1"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>QE</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>El-Mahdy</surname><given-names>MA</given-names></name><name><surname>Wani</surname><given-names>G</given-names></name><etal/></person-group><year>2006</year><article-title>DNA damage binding protein component DDB1 participates in nucleotide excision repair through DDB2 DNA-binding and cullin 4A ubiquitin ligase activity.</article-title><source>Cancer Res</source><volume>66</volume><fpage>8590</fpage><lpage>8597</lpage><pub-id pub-id-type="pmid">16951172</pub-id></mixed-citation></ref><ref id="pone.0007050-Shumaker2"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Tanhehco</surname><given-names>YC</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2001</year><article-title>LAP2 binds to BAF.DNA complexes: requirement for the LEM domain and modulation by variable regions.</article-title><source>EMBO J</source><volume>20</volume><fpage>1754</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">11285238</pub-id></mixed-citation></ref><ref id="pone.0007050-Bengtsson1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2006</year><article-title>Barrier-to-autointegration factor phosphorylation on Ser-4 regulates emerin binding to lamin A in vitro and emerin localization in vivo.</article-title><source>Mol Biol Cell</source><volume>17</volume><fpage>1154</fpage><lpage>1163</lpage><pub-id pub-id-type="pmid">16371512</pub-id></mixed-citation></ref><ref id="pone.0007050-TrinkleMulcahy1"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinkle-Mulcahy</surname><given-names>L</given-names></name><name><surname>Boulon</surname><given-names>S</given-names></name><name><surname>Lam</surname><given-names>YW</given-names></name><name><surname>Urcia</surname><given-names>R</given-names></name><name><surname>Boisvert</surname><given-names>FM</given-names></name><etal/></person-group><year>2008</year><article-title>Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes.</article-title><source>J Cell Biol</source><volume>183</volume><fpage>223</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">18936248</pub-id></mixed-citation></ref><ref id="pone.0007050-Moll1"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moll</surname><given-names>R</given-names></name><name><surname>Divo</surname><given-names>M</given-names></name><name><surname>Langbein</surname><given-names>L</given-names></name></person-group><year>2008</year><article-title>The human keratins: biology and pathology.</article-title><source>Histochem Cell Biol</source><volume>129</volume><fpage>705</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">18461349</pub-id></mixed-citation></ref><ref id="pone.0007050-Joselin1"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joselin</surname><given-names>AP</given-names></name><name><surname>Schulze-Osthoff</surname><given-names>K</given-names></name><name><surname>Schwerk</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>Loss of Acinus inhibits oligonucleosomal DNA fragmentation but not chromatin condensation during apoptosis.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>12475</fpage><lpage>12484</lpage><pub-id pub-id-type="pmid">16537548</pub-id></mixed-citation></ref><ref id="pone.0007050-Wu1"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>K</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year>2008</year><article-title>MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks.</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>11200</fpage><lpage>11205</lpage><pub-id pub-id-type="pmid">18678890</pub-id></mixed-citation></ref><ref id="pone.0007050-Stiff1"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiff</surname><given-names>T</given-names></name><name><surname>Cerosaletti</surname><given-names>K</given-names></name><name><surname>Concannon</surname><given-names>P</given-names></name><name><surname>O'Driscoll</surname><given-names>M</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><year>2008</year><article-title>Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1.</article-title><source>Hum Mol Genet</source><volume>17</volume><fpage>3247</fpage><lpage>3253</lpage><pub-id pub-id-type="pmid">18664457</pub-id></mixed-citation></ref><ref id="pone.0007050-Gant1"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gant</surname><given-names>TM</given-names></name><name><surname>Harris</surname><given-names>CA</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>1999</year><article-title>Roles of LAP2 proteins in nuclear assembly and DNA replication: truncated LAP2beta proteins alter lamina assembly, envelope formation, nuclear size, and DNA replication efficiency in Xenopus laevis extracts.</article-title><source>J Cell Biol</source><volume>144</volume><fpage>1083</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">10087255</pub-id></mixed-citation></ref><ref id="pone.0007050-Sugimura1"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimura</surname><given-names>K</given-names></name><name><surname>Takebayashi</surname><given-names>S</given-names></name><name><surname>Taguchi</surname><given-names>H</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name></person-group><year>2008</year><article-title>PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA.</article-title><source>J Cell Biol</source><volume>183</volume><fpage>1203</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">19103807</pub-id></mixed-citation></ref><ref id="pone.0007050-Lachner1"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachner</surname><given-names>M</given-names></name><name><surname>O'Carroll</surname><given-names>D</given-names></name><name><surname>Rea</surname><given-names>S</given-names></name><name><surname>Mechtler</surname><given-names>K</given-names></name><name><surname>Jenuwein</surname><given-names>T</given-names></name></person-group><year>2001</year><article-title>Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.</article-title><source>Nature</source><volume>410</volume><fpage>116</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">11242053</pub-id></mixed-citation></ref><ref id="pone.0007050-Reisman1"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reisman</surname><given-names>D</given-names></name><name><surname>Glaros</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>EA</given-names></name></person-group><year>2009</year><article-title>The SWI/SNF complex and cancer.</article-title><source>Oncogene</source><volume>28</volume><fpage>1653</fpage><lpage>1668</lpage><pub-id pub-id-type="pmid">19234488</pub-id></mixed-citation></ref><ref id="pone.0007050-Banerjee1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>BR</given-names></name><name><surname>Kundu</surname><given-names>TK</given-names></name></person-group><year>2004</year><article-title>General transcriptional coactivator PC4 activates p53 function.</article-title><source>Mol Cell Biol</source><volume>24</volume><fpage>2052</fpage><lpage>2062</lpage><pub-id pub-id-type="pmid">14966284</pub-id></mixed-citation></ref><ref id="pone.0007050-Kishore1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>AH</given-names></name><name><surname>Batta</surname><given-names>K</given-names></name><name><surname>Das</surname><given-names>C</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Kundu</surname><given-names>TK</given-names></name></person-group><year>2007</year><article-title>p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene.</article-title><source>Biochem J</source><volume>406</volume><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">17555406</pub-id></mixed-citation></ref><ref id="pone.0007050-Das1"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>C</given-names></name><name><surname>Hizume</surname><given-names>K</given-names></name><name><surname>Batta</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>BR</given-names></name><name><surname>Gadad</surname><given-names>SS</given-names></name><etal/></person-group><year>2006</year><article-title>Transcriptional coactivator PC4, a chromatin-associated protein, induces chromatin condensation.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>8303</fpage><lpage>8315</lpage><pub-id pub-id-type="pmid">16982701</pub-id></mixed-citation></ref><ref id="pone.0007050-Mortusewicz1"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortusewicz</surname><given-names>O</given-names></name><name><surname>Roth</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Cardoso</surname><given-names>MC</given-names></name><name><surname>Meisterernst</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Recruitment of RNA polymerase II cofactor PC4 to DNA damage sites.</article-title><source>J Cell Biol</source><volume>183</volume><fpage>769</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">19047459</pub-id></mixed-citation></ref><ref id="pone.0007050-Batta1"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batta</surname><given-names>K</given-names></name><name><surname>Yokokawa</surname><given-names>M</given-names></name><name><surname>Takeyasu</surname><given-names>K</given-names></name><name><surname>Kundu</surname><given-names>TK</given-names></name></person-group><year>2009</year><article-title>Human transcriptional coactivator PC4 stimulates DNA end joining and activates DSB repair activity.</article-title><source>J Mol Biol</source><volume>385</volume><fpage>788</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">19038270</pub-id></mixed-citation></ref><ref id="pone.0007050-Ito1"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Yamamichi</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Tando</surname><given-names>T</given-names></name><etal/></person-group><year>2008</year><article-title>Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).</article-title><source>Biochem J</source><volume>411</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">18042045</pub-id></mixed-citation></ref><ref id="pone.0007050-Engelman1"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>A</given-names></name><name><surname>Cherepanov</surname><given-names>P</given-names></name></person-group><year>2008</year><article-title>The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.</article-title><source>PLoS Pathog</source><volume>4</volume><fpage>e1000046</fpage><pub-id pub-id-type="pmid">18369482</pub-id></mixed-citation></ref><ref id="pone.0007050-Mansharamani1"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansharamani</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>DR</given-names></name><name><surname>Monie</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Hildreth</surname><given-names>JE</given-names></name><etal/></person-group><year>2003</year><article-title>Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virions.</article-title><source>J Virol</source><volume>77</volume><fpage>13084</fpage><lpage>13092</lpage><pub-id pub-id-type="pmid">14645565</pub-id></mixed-citation></ref><ref id="pone.0007050-Mulky1"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulky</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>TV</given-names></name><name><surname>Kozlov</surname><given-names>SV</given-names></name><name><surname>Korbei</surname><given-names>B</given-names></name><name><surname>Foisner</surname><given-names>R</given-names></name><etal/></person-group><year>2008</year><article-title>The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections.</article-title><source>J Virol</source><volume>82</volume><fpage>5860</fpage><lpage>5868</lpage><pub-id pub-id-type="pmid">18400857</pub-id></mixed-citation></ref><ref id="pone.0007050-Wacker1"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wacker</surname><given-names>DA</given-names></name><name><surname>Ruhl</surname><given-names>DD</given-names></name><name><surname>Balagamwala</surname><given-names>EH</given-names></name><name><surname>Hope</surname><given-names>KM</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>The DNA binding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription.</article-title><source>Mol Cell Biol</source><volume>27</volume><fpage>7475</fpage><lpage>7485</lpage><pub-id pub-id-type="pmid">17785446</pub-id></mixed-citation></ref><ref id="pone.0007050-Kim2"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Kraus</surname><given-names>WL</given-names></name></person-group><year>2005</year><article-title>Poly(ADP-ribosyl)ation by PARP-1: &#x02018;PAR-laying&#x02019; NAD&#x0002b; into a nuclear signal.</article-title><source>Genes Dev</source><volume>19</volume><fpage>1951</fpage><lpage>1967</lpage><pub-id pub-id-type="pmid">16140981</pub-id></mixed-citation></ref><ref id="pone.0007050-Puranam1"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puranam</surname><given-names>KL</given-names></name><name><surname>Blackshear</surname><given-names>PJ</given-names></name></person-group><year>1994</year><article-title>Cloning and characterization of RECQL, a potential human homologue of the Escherichia coli DNA helicase RecQ.</article-title><source>J Biol Chem</source><volume>269</volume><fpage>29838</fpage><lpage>29845</lpage><pub-id pub-id-type="pmid">7961977</pub-id></mixed-citation></ref><ref id="pone.0007050-Broers1"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broers</surname><given-names>JL</given-names></name><name><surname>Ramaekers</surname><given-names>FC</given-names></name><name><surname>Bonne</surname><given-names>G</given-names></name><name><surname>Yaou</surname><given-names>RB</given-names></name><name><surname>Hutchison</surname><given-names>CJ</given-names></name></person-group><year>2006</year><article-title>Nuclear lamins: laminopathies and their role in premature ageing.</article-title><source>Physiol Rev</source><volume>86</volume><fpage>967</fpage><lpage>1008</lpage><pub-id pub-id-type="pmid">16816143</pub-id></mixed-citation></ref><ref id="pone.0007050-Shumaker3"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Solimando</surname><given-names>L</given-names></name><name><surname>Sengupta</surname><given-names>K</given-names></name><name><surname>Shimi</surname><given-names>T</given-names></name><name><surname>Adam</surname><given-names>SA</given-names></name><etal/></person-group><year>2008</year><article-title>The highly conserved nuclear lamin Ig-fold binds to PCNA: its role in DNA replication.</article-title><source>J Cell Biol</source><volume>181</volume><fpage>269</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">18426975</pub-id></mixed-citation></ref><ref id="pone.0007050-Tagami1"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagami</surname><given-names>H</given-names></name><name><surname>Ray-Gallet</surname><given-names>D</given-names></name><name><surname>Almouzni</surname><given-names>G</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name></person-group><year>2004</year><article-title>Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis.</article-title><source>Cell</source><volume>116</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">14718166</pub-id></mixed-citation></ref><ref id="pone.0007050-Furuyama1"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuyama</surname><given-names>T</given-names></name><name><surname>Dalal</surname><given-names>Y</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Chaperone-mediated assembly of centromeric chromatin in vitro.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>6172</fpage><lpage>6177</lpage><pub-id pub-id-type="pmid">16601098</pub-id></mixed-citation></ref><ref id="pone.0007050-Groth1"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groth</surname><given-names>A</given-names></name><name><surname>Rocha</surname><given-names>W</given-names></name><name><surname>Verreault</surname><given-names>A</given-names></name><name><surname>Almouzni</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>Chromatin challenges during DNA replication and repair.</article-title><source>Cell</source><volume>128</volume><fpage>721</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">17320509</pub-id></mixed-citation></ref><ref id="pone.0007050-Reinberg1"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinberg</surname><given-names>D</given-names></name><name><surname>Sims</surname><given-names>RJ</given-names><suffix>3rd</suffix></name></person-group><year>2006</year><article-title>de FACTo nucleosome dynamics.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>23297</fpage><lpage>23301</lpage><pub-id pub-id-type="pmid">16766522</pub-id></mixed-citation></ref><ref id="pone.0007050-Scaffidi2"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaffidi</surname><given-names>P</given-names></name><name><surname>Misteli</surname><given-names>T</given-names></name></person-group><year>2006</year><article-title>Lamin A-dependent nuclear defects in human aging.</article-title><source>Science</source><volume>312</volume><fpage>1059</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">16645051</pub-id></mixed-citation></ref><ref id="pone.0007050-Sridharan1"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridharan</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>WC</given-names></name><name><surname>McMahon</surname><given-names>LW</given-names></name><name><surname>Lambert</surname><given-names>MW</given-names></name></person-group><year>2003</year><article-title>Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links.</article-title><source>J Cell Sci</source><volume>116</volume><fpage>823</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">12571280</pub-id></mixed-citation></ref><ref id="pone.0007050-Sridharan2"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridharan</surname><given-names>DM</given-names></name><name><surname>McMahon</surname><given-names>LW</given-names></name><name><surname>Lambert</surname><given-names>MW</given-names></name></person-group><year>2006</year><article-title>alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus.</article-title><source>Cell Biol Int</source><volume>30</volume><fpage>866</fpage><lpage>878</lpage><pub-id pub-id-type="pmid">16889989</pub-id></mixed-citation></ref><ref id="pone.0007050-Holaska2"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holaska</surname><given-names>JM</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><year>2007</year><article-title>An emerin &#x0201c;proteome&#x0201d;: purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.</article-title><source>Biochemistry</source><volume>46</volume><fpage>8897</fpage><lpage>8908</lpage><pub-id pub-id-type="pmid">17620012</pub-id></mixed-citation></ref><ref id="pone.0007050-Shevchenko1"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevchenko</surname><given-names>A</given-names></name><name><surname>Wilm</surname><given-names>M</given-names></name><name><surname>Vorm</surname><given-names>O</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year>1996</year><article-title>Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.</article-title><source>Anal Chem</source><volume>68</volume><fpage>850</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">8779443</pub-id></mixed-citation></ref><ref id="pone.0007050-Keller1"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name><name><surname>Kolker</surname><given-names>E</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><year>2002</year><article-title>Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.</article-title><source>Anal Chem</source><volume>74</volume><fpage>5383</fpage><lpage>5392</lpage><pub-id pub-id-type="pmid">12403597</pub-id></mixed-citation></ref><ref id="pone.0007050-Nesvizhskii1"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Kolker</surname><given-names>E</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>A statistical model for identifying proteins by tandem mass spectrometry.</article-title><source>Anal Chem</source><volume>75</volume><fpage>4646</fpage><lpage>4658</lpage><pub-id pub-id-type="pmid">14632076</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was funded by the American Heart Association (predoctoral fellowship 0615601U to RM) and the National Institutes of Health (RO1 GM48646 to KLW). These funding sponsors had no role in the design, interpretation, writing or publication of this work.</p></fn></fn-group></back></article>